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METHODS AND MATERIALS FOR MAKING them. Id. Dicamba is chemically stable and can sometimes 
AND USING TRANSGENIC be persistent in the environment. 
DICAMBA-DEGRADING ORGANISMS Dicamba is in the class of benzoic acid herbicides. It has 
been suggested that plants tolerant to benzoic acid herbi- 
This application is a continuation-in-part of application 5 cides, including dicamba, can be produced by incorporating 
Ser. No. 091055,145, filed Apr. 3, 1998, and claims benefit a 1-aminocyclopropane-1-carboxylic acid (ACC) synthase 
of provisional application 601042,666 and 601042,941, both antisense gene, an ACC oxidase antisense gene, an ACC 
filed Apr. 4, 1997, the complete disclosures of all three of deaminase gene, or combinations thereof, into the plants. 
which are incorporated herein by reference. See Canadian Patent Application 2,165,036 (published Jun. 
l o  16, 1996). However, no experimental data are presented in 
FIELD OF THE INVENTION this application which demonstrate such tolerance. 
Bacteria that metabolize dicamba are known. See U.S. 
The present invention relates to transgenic organisms that Pat. No. 5,445,962; Krueger et al., J. Agric. Food Chem., 37, 
are able to degrade the herbicide dicamba, including trans- 534-538 (1989); Cork and Krueger, Adv. Appl. Microbial., 
genic plants that have been made tolerant to dicamba. The 1s 38, 1-66 (1991); Cork and Khalil, Adv. Appl. Microbiol., 40, 
invention also relates to dicamba-degrading enzymes and to 289-320 (1995). It has been suggested that the specific 
DNA molecules and DNA constructs coding for dicamba- genes responsible for dicamba metabolism by these bacteria 
degrading enzymes. The invention further relates to a could be isolated and used to produce dicamba-resistant 
method of controlling weeds in fields of dicamba-tolerant plants and other organisms. See id. and Yang et al., Anal. 
transgenic plants and to a method of removing dicamba from 20 Biochem., 219:3742 (1994). However, prior to the present 
materials contaminated with it (bioremediation). Finally, the invention, no such genes had been identified or isolated. 
invention relates to methods of selecting transformants 
based on dicamba tolerance or on detecting the fluorescence SUMMARY OF THE INVENTION 
of 3,6-dichlorosalicylic acid which is generated as a result of 
dicamba degradation. 25 The invention provides an isolated and at least partially 
purified dicamba-degrading 0-demethylase, an isolated and 
BACKGROUND at least partially purified dicamba-degrading oxygenase, an 
isolated and at least partially purified dicamba-degrading 
Herbicides are used routinely in agricultural production. ferredoxin, and an isolated and at least partially purified 
Their effectiveness is often determined by their ability to kill 30 dicamba-degrading reductase, all as defined and described 
weed growth in crop fields and the tolerance of the cash crop below. 
to the herbicide. If the cash crop is not tolerant to the The invention also provides an isolated DNA molecule 
herbicide, the herbicide will either diminish the productivity comprising a DNA sequence coding for a dicamba-degrad- 
of the cash crop or kill it altogether. Conversely, if the 
herbicide is not strong enough, it may allow too much weed 
growth in the crop field which will, in turn, lessen the 
productivity of the cash crop. Therefore, it is desirable to 
produce economically important plants which are tolerant to 
herbicides. To protect the water and environmental quality 
of agricultural lands, it is also desirable to develop tech- 
nologies to degrade herbicides in cases of accidental spills of 
the herbicide or in cases of unacceptably high levels of soil 
or water contamination. 
ing oxygenase, an isolated DNA molecule comprising a 
35 DNA sequence coding for a dicamba-degrading ferredoxin, 
and an isolated DNA molecule comprising a DNA sequence 
coding for a dicamba-degrading reductase. The invention 
further provides a DNA construct comprising a DNA 
sequence coding for a dicamba-degrading oxygenase, a 
40 DNA sequence coding for a dicamba-degrading ferredoxin, 
or a DNA sequence coding for a dicamba-degrading reduc- 
tase, each DNA coding sequence being operatively linked to 
expression control sequences. In addition, the invention 
Genes encoding enzymes which inactivate herbicides and provides a DNA construct comprising a DNA sequence 
other xenophobic compounds have previously been isolated 45 coding for a dicamba-degrading oxygenase, a DNA 
from a variety of procaryotic and eucaryotic organisms. In sequence coding for a dicamba-degrading ferredoxin, and a 
some cases, these genes have been genetically engineered DNA sequence coding for a dicamba-degrading reductase, 
for successful expression in plants. Through this approach, each DNA coding sequence being operatively linked to 
plants have been developed which are tolerant to the herbi- expression control sequences. 
cides 2,4-dichlorophenoxyacetic acid (Streber and Will- 50 The invention further provides a transgenic host cell 
mitzer (1 989) Bio/Echnology 7:811-816; 2,4-D), bromoxy- comprising DNA coding for a dicamba-degrading oxyge- 
nil (Stalker et al. (1988) Science 242:419-423; tradename nase, DNA coding for a dicamba-degrading ferredoxin, or 
Buctril), glyphosate (Comai et al. (1985) Nature DNA coding for a dicamba-degrading reductase, each DNA 
3 17:741-744; tradename Round-Up) and phosphinothricin being operatively linked to expression control sequences. In 
(De Block et al. (1 987) EMBO J. 6:25 13-25 18; tradename 55 addition, the invention provides a transgenic host cell com- 
Basta). prising DNA coding for a dicamba-degrading oxygenase and 
Dicamba (tradename Banvel) is used as a pre-emergent DNA coding for a dicamba-degrading ferredoxin, DNA 
and post-emergent herbicide for the control of annual and coding for a dicamba-degrading reductase, or DNA coding 
perennial broadleaf weeds and several grassy weeds in corn, for a dicamba-degrading ferredoxin and DNA coding for a 
sorghum, small grains, pasture, hay, rangeland, sugarcane, 60 dicamba-degrading reductase, each DNA being operatively 
asparagus, turf and grass seed crops. See Crop Protection linked to expression control sequences. The transgenic host 
Reference, pages 1803-1821 (Chemical & Pharmaceutical cell may be a plant cell or a prokaryotic or eukaryotic 
Press, Inc., New York, N.Y., 11th ed., 1995). Unfortunately, microorganism. 
dicamba can injure many commercial crops (including The invention also provides a transgenic plant or plant 
beans, soybeans, cotton, peas, potatoes, sunflowers, toma- 65 part comprising one or more cells comprising DNA coding 
toes, tobacco, and fruit trees), ornamental plants and trees, for a dicamba-degrading oxygenase, DNA coding for a 
and other broadleaf plants when it comes into contact with dicamba-degrading ferredoxin, or DNA coding for a 
US 7,105,724 B2 
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dicamba-degrading reductase, each DNA being operatively family of ferredoxins. In FIG. 2, ferr di6Gferredoxin com- 
linked to expression control sequences. The invention fur- ponent of dicamba 0-demethylase from Pseudomonas mal- 
ther provides a transgenic plant or plant part comprising one tophilia DI-6 [SEQ ID NO:5]; fer6 rhoca=ferredoxin from 
or more cells comprising DNA coding for a dicamba- Rhodobacter capsulatus [SEQ ID NO:10]; fer 
degrading oxygenase and DNA coding for a dicamba- 5 caucr=ferredoxin from Caulobacter crescentus [SEQ ID 
degrading ferredoxin, DNA coding for a dicamba-degrading NO: 1 1] ; thcc rhocr=ferredoxin from Rhodococcus elythro- 
reductase, or DNA coding for a dicamba-degrading ferre- polis [SEQ ID NO:12]; putx psepu=ferredoxin from 
doxin and DNA coding for a dicamba-degrading reductase, Pseudomonas putida [SEQ ID NO: 131; terp 
each DNA being operatively linked to expression control psesp=ferredoxin from Pseudomonas sp. [SEQ ID NO:14]. 
sequences. The transgenic plant or plant part is preferably l o  Also in FIG. 2, the numbers 1-3 designate the three con- 
tolerant to dicamba or has had its tolerance to dicamba served motifs of the adrenodoxin family of bacterial ferre- 
increased as a result of the expression of the dicamba- doxins. 
degrading enzyme(s). FIG. 3. Comparison of the derived amino acid sequence 
The invention also provides a method of controlling of the two reductase components of dicamba 0-demethylase 
weeds in a field containing transgenic dicamba-tolerant 15 to the ,in, acid sequences of members of the family of 
plants. The method an FAD-dependent pyridine nucleotide reductases. In FIG. 3, 
dicamba to the field which is effective to control the weeds. di6=reductase component of dicamba 0-demethylase 
The invention further provides methods of decontaminat- from p maltophilia DI-6 [SEQ ID NO:7]; red2 
ing a material containing dicamba. In one embodiment, the di6=reductase component of dicamba 0-demethylase from 
method comprises applying an effective amount of a trans- 20 p maltophilia DI-6 [SEQ ID NO:9]; AJ002606=reductase 
genic dicamba-degrading microorganism to the material. In from  hi^^^^^^^^ sp, [SEQ ID ~ 0 : 1 5 ] ;  thcd 
another embodiment, the method comprises applying an rhoer=reductase from R. erythropolis [SEQ ID NO:16]; 
effective amount of a dicamba-degrading 0-demethylase or psepu=reductase from p putida [SEQ ID NO: 171; tera 
a a dicamba-degrading Oxygenase, a pscsp=reductase from Pseudomonas sp. [SEQ ID NO: 181. 
dicamba-degrading ferredoxin and a dicamba-degrading 25 Also in FIG. 3, the numbers 1-5 designate the five conserved 
reductase to the material. motifs of FAD-dependent pyridine nucleotide reductases. 
The invention also provides a method of selecting trans- 
formed plant cells and transformed plants using dicamba 
tolerance as the selection marker. In one embodiment, the DETAILED DESCRIPTION OF THE 
method comprises transforming at least some of the plant 30 PRESENTLY PREFERRED EMBODIMENTS OF THE INVENTION 
cells in a population of plant cells so that they are tolerant 
to dicamba and growing the resulting population of plant 
cells in a culture medium containing dicamba at a concen- studies and Kreuger, Advan. A ~ ~ l .  MicrobiO1. 
tration selected so that transformed plant cells will grow and 36:1-56 and Yang et Biochem. 219:37-42) 
untransformed plant cells will not grow. In another embodi- 35 shown that the bacterium, Pseudomonas 
merit, the method comprising applying dicamba to a popu- philia, strain DI-6, is capable of destroying the herbicidal 
lation of plants suspected of comprising plants that have activity dicamba through a sing1e step in which 
been transformed so that they are tolerant to dicamba, the dicamba (3,6-dich10r0-2-meth0x~benz0ic acid) is 
dicamba being applied in an amount selected so that trans- 3>6-dich10r0sa1ic~1ic a id (3,6-DCSA). 3,6-DCSA has no 
formed plants will grow, and the growth of untransformed 40 activity and has not been shown to have any 
plants will be inhibited. detrimental effects on plants. In addition, 3,6-DCSA is 
Finally, the invention provides a method of selecting, or readily degraded by the normal bacterial flora present in soil. 
screening for, transformed host cells, intact organisms, and The experiments described herein confirm the hypothesis 
parts of organisms, l-he method comprises providing a of Yang et al. (see id.) that an 0-demethylase is responsible 
population of host cells, intact organisms, or parts of organ- 45 for the conversion of dicamba to 3,6-DCSA by p malto- 
isms suspected ofcomp~sing host cells, intact organisms, or philia strain DI-6 and establish that the 0-demethylase is a 
parts of organisms that have been transformed so that they three-component enzyme system consisting of a reductase, 
are able to degrade dicamba, contacting the population of a ferredoxin, andanoxygenase. See Examples 1 and3 which 
host cells, intact organisms, or parts of organisms with describe in detail the isolation, purification and character- 
dicamba, and ascertaining the presence or level of fluores- 50 ization of the P maltophilia 0-demethylase and its three 
cence due to 3 , ~ - ~ i c ~ ~ o r o s a ~ i c y ~ i c  acid, l-he 3,6-dichloro- components. The reaction scheme for the reaction catalyzed 
salicyclic acid is generated in transformed host cells, intact by the three components of dicamba O-demeth~lase is 
organisms, or parts of organisms as a result of the degrada- presented in FIG. 1. As illustrated in FIG. 1, electrons from 
tion of dicamba, but will not be generated in untransformed NADH are shuttled through a short electron chain consisting 
host cells, intact organisms, or parts of organisms. 55 of the reductase and ferredoxin to the terminal oxygenase 
which catalyzes the oxidation of dicamba to produce 3,6- 
BRIEF DESCRIPTION OF THE DRAWINGS DCSA. 
In a first embodiment, the invention provides isolated and 
FIG. 1. A diagram of the proposed electron transport at least partially purified dicamba-degrading enzymes. "Iso- 
scheme for dicamba 0-demethylase. Electrons from NADH 60 lated" is used herein to mean that the enzymes have at least 
are transferred sequentially from reductaseDrc to ferredox- been removed from the cells in which they are produced 
inDrc and then to oxygenaseDrc The reaction of oxygen with (i.e., they are contained in a cell lysate). "At least partially 
the substrate dicamba to form 3,6-dichlorosalicylic acid is purified" is used herein to mean that they have been sepa- 
catalyzed by oxygenase,,,. ox, oxidized; red, reduced. rated at least partially from the other components of the cell 
FIG. 2. Comparison of the derived amino acid sequence 65 lysate. Preferably, the enzymes have been purified suffi- 
of the ferredoxin component of dicamba 0-demethylase to ciently so that the enzyme preparations are at least about 
the amino acid sequences of members of the adrenodoxin 70% homogenous. 
US 7,105,724 B2 
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In particular, the invention provides an isolated and at grading bacterial strains can be isolated as were these strains 
least partially purified dicamba-degrading 0-demethylase. by methods well known in the art. 
"Dicamba-degrading 0-demethylase" is defined herein to Preferably, however, the dicamba-degrading enzymes of 
mean a combination of a dicamba-degrading oxygenase, a the invention are prepared using recombinant DNA tech- 
dicamba-degrading ferredoxin and a dicamba-degrading 5 niques (see below). In particular, mutant enzymes having the 
reductase, all as defined below. amino acid sequence of the P maltophilia enzyme wherein 
ne invention also provides an isolated and at least one or more amino acids have been added to, deleted from, 
partially purified dicamba-degrading oxygenase, a~icamba- or substituted for, the amino acids of the P maltophilia 
degrading oxygenase" is defined herein to mean the oxyge- Sequence are prepared in this n~anner using, for example, 
nase purified from p maltophilia strain DI-6 and oxygenases 10 oligonucleotide-directed mutagenesis, linker-scanning 
which have an amino acid sequence which is at least about mutagenesis, mutagenesis using the polymerase chain reac- 
65% homologous, preferably at least about 85% homolo- tion, and the like. See h s u b e l  et al. (eds.1, Current Proto- 
gous, to that of the P maltophilia oxygenase and which can cols In Molecular Biology   wile^ Interscience 1990) and 
participate in the degradation of dicamba, a~icamba-de- McPherson (ed.), Directed Mutagenesis: A Practical 
grading oxygenases" include mutant oxygenases having the 15 APP~oach ( I K  Press 1991). 
amino acid sequence of the p maltophilia oxygenase In a second embodiment, the invention provides isolated 
wherein one or more amino acids have been added to, DNA molecules coding for dicamba-degrading enzymes of 
deleted from, or substituted for, the amino acids of the p the invention. "Isolated" is used herein to mean that the 
maltophilia oxygenase sequence, ~ ~ t i ~ i t y  of dicamba-de- DNA molecule has been removed from its natural environ- 
grading oxygenases can be determined as described in 20 ment or is not a naturally-occurring DNAmolecule. Meth- 
Examples 1 and 3. ods of preparing these DNAmolecules are well known in the 
The invention further provides an isolated and at least art. See, e.g., Maniatis et al., Molecular Cloning: A Labo- 
partially purified dicamba-degrading ferredoxin, "Dicamba- ratory Harbor, N.Y. 982), 'ambrook 
degrading ferredoxinX is defined herein to mean the ferre- et al.' Molecular Cloning: A Laboratoly Manual, Cold 
doxin purified from P maltophilia strain DI-6 and ferredox- 25 'pring Harbor, N.Y. (1989). 
ins which have an amino acid sequence which is at least For instance, the DNAmolecules of the invention may be 
about 65% homologous, preferably at least about 85% isolated cDNA or genomic clones. The identification and 
homologous, to that of the p maltophilia ferredoxin and isolation of clones coding for the dicamba-degrading 
which can participate in the degradation of dicamba, enzymes of P maltophilia strain DI-6 are described in 
"Dicamba-degrading ferredoxins,, include mutant ferredox- 30 Examples 2 and 4-5. Additional clones coding for dicamba- 
ins having the amino acid sequence of the maltophilia degrading enzymes can be obtained in a similar manner. The 
ferredoxin wherein one or more amino acids have been Or portions them, can be used as probes 
added to, deleted from, or for, the amino acids of to identify and isolate additional clones from organisms 
the maltophilia ferredoxin sequence, Activity of dicamba- other than the ones from which the clones were originally 
degrading ferredoxins can be as described in 35 isolated. Suitable organisms include bacteria that degrade 
Examples 1 and 3. dicamba. As noted above, in addition to P maltophilia strain 
DI-6, several strains of bacteria are known that degrade Finally, the invention provides an isolated and at least dicamba, See U,S, Pat, No, 5,445,962; Krueger et al,, J, partially purified dicamba-degrading reductase. "Dicamba- Agric, Food Chem,, 37, 534-538 (1989); Cork and b e g e r ,  degrading reductase" is defined herein to mean the reduc- 40 Adv. Appl, Microbial,, 38, (1991); Cork and Khalil, 
tases purified from P maltophilia strain DI-6 and reductases Adv. Appl, Microbial,, 40, 289-320 (1995), 
which have an amino acid sequence which is at least about The DNA molecules of the invention can also be chemi- 
65% preferably at least 85% homolo- cally synthesized using the sequences of isolated clones, 
gous, to that of one of the P maltophilia reductases and Such techniques are well known in the art, For instance, 
which can participate in the degradation of dicamba. 45 DNA sequences be synthesized by phosphoamidite 
"Dicamba-degrading reductases" include mutant reductases chemistry in an automated DNA synthesizer, Chemical having the amino acid sequence of one of the P maltophilia synthesis has a number of advantages, In particular, chemi- 
reductases wherein One Or amino acids have been cal synthesis is desirable because codons preferred by the 
added to, deleted from, or substituted for, the amino acids of host in which the DNA sequence will be expressed may be 
the P maltophilia reductase sequence. Activity of dicamba- 50 used to optimize expression, Not all of the codons need to 
degrading reductases can be determined as described in be altered to improved expression, but preferably at Examples 1 and 3. least the codons rarely used in the host are changed to 
hfethods of determining the degree of homology of amino host-preferred codons. High levels of expression can be 
acid sequences are well known in the art. For instance, the obtained by changing greater than about 50%, most prefer- 
F E T A  Program of the Genetics Computing Group (GCG) 55 ably at least about SO%, of the codons to host-preferred 
software package (University of Wisconsin, Madison, Wis.1 codons. The codon preferences of many host cells are 
can be used to compare sequences in various protein data- known, see, e,g,, ~ ~ ~ i ~ i ~ i ~ ~  G~~~ ~ ~ ~ ~ ~ ~ ~ i ~ ~ ,  pages 
bases such as the Swiss Protein Database. 225-85 (Reznikoff & Gold, eds., 1986), PCT WO 97131115, 
The dicamba-degrading enzymes of the invention can be PCT WO 97111086, EP 646643, EP 553494, and U.S. Pat. 
isolated and purified as described in Examples 1 and 3 from 60 Nos. 5,689,052, 5,567,862, 5,567,600, 5,552,299 and 5,017, 
P maltophilia or other organisms. Suitable other organisms 692. The codon preferences of other host cells can be 
include bacteria other than P maltophilia strain DI-6 that deduced by methods known in the art. Also, using chemical 
degrade dicamba. Several strains of such bacteria are synthesis, the sequence of the DNA molecule or its encoded 
known. See U.S. Pat. No. 5,445,962; Krueger et al., J. Agric. protein can be readily changed to, e.g., optimize expression 
Food Chem., 37, 534-538 (989); Cork and Krueger, Adv. 65 (e.g., eliminate mRNA secondary structures that interfere 
Appl. Microbiol., 38, 1-66 (1991); Cork and Khalil, Adv. with transcription or translation), add unique restriction sites 
Appl. Microbiol., 40, 289-320 (1995). Other dicamba-de- at convenient points, delete protease cleavage sites, etc. 
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In a third embodiment, the present invention provides plants do not normally respond. An exemplary inducible 
DNA constructs comprising DNA coding for a dicamba- promoter of this type is the inducible promoter from a 
degrading enzyme operatively linked to expression control steroid hormone gene, the transcriptional activity of which 
sequences or a plurality of DNA coding sequences, each is induced by a glucocorticosteroid hormone. Schena et al., 
coding for a dicamba-degrading enzyme and each being 5 Proc. Natl. Acad. Sci. USA 88:10421 (1991). Other inducible 
operatively linked to expression control sequences. "DNA promoters for use in plants are described in EP 332104, PCT 
constructs" are defined herein to be constructed (non-natu- WO 93121334 and PCT WO 97106269. 
rally occurring) DNAmolecules useful for introducing DNA Suitable promoters for use in bacteria include the pro- 
into host cells, and the term includes chimeric genes, expres- moter of the Bacillus stearothermophilus maltogenic amy- 
sion cassettes, and vectors. 10 lase gene, the Bacillus lichenformis alpha-amylase gene, the 
As used herein "operatively linked" refers to the linking Bacillus amyloliquefaciens BAN amylase gene, the Bacillus 
of DNA sequences (including the order of the sequences, the subtilis alkaline protease gene, the Bacillus pumilus xylosi- 
orientation of the sequences, and the relative spacing of the dase gene, the phage lambda P, and P, promoters, and the 
various sequences) in such a manner that the encoded Escherichia coli lac, trp and tac promoters. See PCT WO 
proteins are expressed. Methods of operatively linking 1s 96123898 and PCT WO 97142320. 
expression control sequences to coding sequences are well Suitable promoters for use in yeast host cells include 
known in the art. See, e.g., Maniatis et al., Molecular promoters from yeast glycolytic genes, promoters from 
Cloning: A Laboratoy Manual, Cold Spring Harbor, N.Y. alcohol dehydrogenase genes, the TPIl promoter, and the 
(1982), Sambrook et al., Molecular Cloning: A Laboratory ADH2-4c promoter. See PCT WO 96123898. 
Manual, Cold Spring Harbor, N.Y. (1989). 20 Suitable promoters for use in filamentous fungi include 
"Expression control sequences" are DNA sequences the ADH3 promoter, the tpiA promoter, the promoters of the 
involved in any way in the control of transcription or genes encoding Aspergillus oryzae TAKA amylase, Rhizo- 
translation in prokaryotes and eukaryotes. Suitable expres- mucor miehei aspartic proteinase, Aspergillus niger neutral 
sion control sequences and methods of making and using alpha-amylase, A. niger acid stable alpha-amylase, A. niger 
them are well known in the art. 25 or Aspergillus awamori glucoamylase, R. miehei lipase, A. 
The expression control sequences must include a pro- oyzae  alkaline protease, A. oyzae  triose phosphate 
moter. The promoter may be any DNA sequence which isomerase, and Aspergillus nidulans acetamidase. See PCT 
shows transcriptional activity in the chosen host cell or WO 96123898. 
organism. The promoter may be inducible or constitutive. It Suitable promoters for use in mammalian cells are the 
may be naturally-occurring, may be composed of portions of 30 SV40 promoter, metallothionein gene promoter, murine 
various naturally-occuring promoters, or may be partially or mammary tumor virus promoter, Rous sarcoma virus pro- 
totally synthetic. Guidance for the design of promoters is moter, and adenovirus 2 major late promoter. See PCT WO 
provided by studies of promoter structure, such as that of 96123898 and PCT WO 97142320. 
Harley and Reynolds, Nucleic Acids Res., 15, 2343-61 Suitable promoters for use in insect cells include the 
(1987). Also, the location of the promoter relative to the 35 polyhedrin promoter, PI0 promoter, the Autographa cali- 
transcription start may be optimized. See, e.g., Roberts, et fornica polyhedrosis virus basic protein promoter, the bacu- 
al., Proc. Natl. Acad. Sci. USA, 76, 7 6 0 4  (1 979). Many lovirus immediate early gene 1 promoter and the baculovirus 
suitable promoters for use in prokaryotes and eukaryotes are 39K delayed-early gene promoter. See PCT WO 96123898. 
well known in the art. Finally, promoters composed of portions of other promot- 
For instance, suitable constitutive promoters for use in 40 ers and partially or totally synthetic promoters can be used. 
plants include: the promoters from plant viruses, such as the See, e.g., Ni et al., Plant J., 7:661-676 (1995) and PCT WO 
35s promoter from cauliflower mosaic virus (Ode11 et al., 95114098 describing such promoters for use in plants. 
Nature 313:810-812 (1 985), promoters of Chlorella virus The promoter may include, or be modified to include, one 
methyltransferase genes (U.S. Pat. No. 5,563,328), and the or more enhancer elements. Preferably, the promoter will 
full-length transcript promoter from figwort mosaic virus 45 include a plurality of enhancer elements. Promoters con- 
(U.S. Pat. No. 5,378,619); the promoters from such genes as taining enhancer elements provide for higher levels of 
rice actin (McElroy et al., Plant Cell 2: 163-171 (1 990)), transcription as compared to promoters which do not include 
ubiquitin (Christensen et al., Plant Mol. Biol. 12:619-632 them. Suitable enhancer elements for use in plants include 
(1989) and Christensen et al., Plant Mol. Biol. 18:675-689 the 35s enhancer element from cauliflower mosaic virus 
(1992)), pEMU (Last et al., Theol: Appl. Genet. 81:581-588 50 (U.S. Pat. Nos. 5,106,739 and 5,164,316) and the enhancer 
(1991)), MAS (Veltenet al., EMBOJ. 3:2723-2730 (1984)), element from figwort mosaic virus (Maiti et al., Transgenic 
maize H3 histone (Lepetit et al., Mol. Gen. Genet. 23 1 : Res., 6, 143-1 56 (1 997)). Other suitable enhancers for use in 
276-285 (1992) and Atanassova et al., Plant Journal 2 other cells are known. See PCT WO 96123898 and Enhanc- 
(3):291-300 (1992)), Brassica napus ALS3 (PCT applica- ers And Eukaryotic Expression (Cold Spring Harbor Press, 
tion WO 97141228); and promoters of various Agrobacte- 55 Cold Spring Harbor, N.Y., 1983). 
rium genes (see U.S. Pat. Nos. 4,771,002, 5,102,796, 5,182, For efficient expression, the coding sequences are pref- 
200, 5,428,147). erably also operatively linked to a 3' untranslated sequence. 
Suitable inducible promoters for use in plants include: the The 3' untranslated sequence contains transcription andor 
promoter from the ACE1 system which responds to copper translation termination sequences. The 3' untranslated 
(Mett et al. PNAS 90:4567-4571 (1993)); the promoter of 60 regions can be obtained from the flanking regions of genes 
the maize In2 gene which responds to benzenesulfonamide from bacterial, plant or other eukaryotic cells. For use in 
herbicide safeners (Hershey et al., Mol. Gen. Genetics prokaryotes, the 3' untranslated region will include a tran- 
227:229-237 (1991) and Gatz et al., Mol. Gen. Genetics scription termination sequence. For use in plants and other 
243:32-38 (1994)), and the promoter of the Tet repressor eukaryotes, the 3' untranslated region will include a tran- 
from TnlO (Gatz et al., Mol. Gen. Genet. 227:229-237 65 scription termination sequence and a polyadenylation 
(1991). A particularly preferred inducible promoter for use sequence. Suitable 3' untranslated sequences for use in 
in plants is one that responds to an inducing agent to which plants include those of the cauliflower mosaic virus 35s 
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gene, the phaseolin seed storage protein gene, the pea (1984), green fluorescent protein (GFP) (Chalfie et al., 
ribulose biphosphate carboxylase small subunit E9 gene, the Science 263:802 (1994), Haseloff et al., TZG 11:328-329 
soybean 7 s  storage protein genes, the octopine synthase (1995) and PCT application WO 97141228). Another 
gene, and the nopaline synthase gene. approach to the identification of relatively rare transforma- 
In plants and other eukaryotes, a 5' untranslated sequence 5 tion events has been use of a gene that encodes a dominant 
is also employed. The 5' untranslated sequence is the portion constitutive regulator of the Zea mays anthocyanin pigmen- 
of an mRNA which extends from the 5' CAP site to the tation pathway. Ludwig et al., Science 247:449 (1990). 
translation initiation codon. This region of the mRNA is suitable selection markers for use in prokaryotes and 
necessary for translation initiation in eukaryotes and plays a eukaryotes other than plants are also well known, see, e,g,, 
role in the regulation of gene expression. Suitable 5' untrans- l o  p c ~  wo 96123898 and PCT wo 97142320, F~~ instance, 
lated regions for use in plants include those of alfalfa mosaic resistance to antibiotics (ampicillin, kanamycin, tetracyline, 
virus, cu~umber mosaic virus coat protein gene, and tobacco chloramphenicol, neomycin or hygromycin) may be used as 
mosaic virus. the selection marker. 
As noted above, the DNA construct may be a vector. The According to another aspect of the present invention, 
vector may contain one or more replication systems which 1s tolerance to dicamba can be used as a selection marker for 
allow it to replicate in host cells. Self-replicating vectors plants and plant cells, ''Tolerance,, means that transformed 
include plasmids, cosmids and viral vectors. Alternatively, plant cells are able to grow (survive and regenerate into 
the may be an integrating which the plants) when placed in culture medium containing a level of 
integration into the host cell's chromosome of the sequences dicamba that prevents untransformed cells from doing so, 
coding for the dicamba-degrading enzymes of the invention. 20 also means that transformed plants are able to 
The vector desirably also has unique restriction sites for the grow after application of an amount of dicamba that inhibits 
insertion of DNA sequences. If a vector does not have the growth of untransformed plants, 
unique restriction sites, it may be modified to introduce or 
eliminate restriction sites to make it more suitable for further Methods of transformed plant are 
manipulations. 25 known in the art. Briefly, at least some of the plant cells in 
The DNA constructs of the invention can be used to a population plant (e.g., an explant Or an 
transform a variety of host cells (see below), A genetic suspension culture) are transformed with a DNAconstruct or 
marker must be used for selecting transformed host cells DNA providing for dicamba 
selection marker"), Selection markers typically allow trans- The population plant is placed 
formed cells to be recovered by negative selection (i,e,, 3o in culture medium containing dicamba at a concentration 
inhibiting growth of cells that do not contain the selection selected so that transformed plant cells will grow, whereas 
marker) or by screening for a product encoded by the untransformed plant cells will not. Suitable concentrations 
selection marker. of dicamba can be determined empirically as is known in the 
The most commonly used selectable marker gene for art. 
plant transformation is the neomycin phosphotransferase I1 35 Methods of selecting transf~rmed plants are also known 
(nptII) gene, isolated from Tn5, which, when placed under in the art. Briefly, dicamba is applied to a population of 
the control of plant regulatory signals, confers resistance to plants suspected of comprising a DNA construct or a corn- 
kanamycin, ~~~l~~ et al,, proc, ~ ~ t l ,  ~ ~ ~ d ,  sci, USA, bination of DNA constructs providing for dicamba degra- 
80:4803 (1983). h o t h e r  commonly used selectable marker dation. The amount of dicamba is selected so that trans- 
gene is the hygromycin phosphotransferase gene which 40 formed plants will grow, and the growth of untransf~rmed 
confers resistance to the antibiotic hygromycin, vanden plants will be inhibited. The level of inhibition must be 
Elzen et al., Plant Mol. Biol., 5:299 (1985). sufficient so that transformed and untransformed plants can 
~ d d i t i ~ ~ ~ l  marker genes of bacterial origin that be readily distinguished (i.e., inhibition must be statistically 
confer resistance to antibiotics include gentamycin acetyl significant). Suchanounts can be determined empirically as 
transferase, streptomycin phosphotransferase, aminoglyco- 45 is known in the art. 
side-3'-adenyl transferase, and the bleomycin resistance Further, the generation of 3,6-DCSA as a result of the 
determinant. Hayford et al., Plant Physiol. 86:1216 (1988), degradation of dicamba can be used for selection and 
Jones et al., Mol. Gen. Genet. 210:86 (1987), Svab et al., screening. The generation of 3,6-DCSA can be readily 
Plant Mol. Biol. 14: 197 (1 990), Hille et al., Plant Mol. Biol. ascertained by observing the fluorescence of this compound, 
7:171 (1986). Other selectable marker genes confer resis- 50 allowing selection and screening of transformed host cells, 
tance to herbicides such as glyphosate, glufosinate or bro- intact organisms, and parts of organisms (e.g., microorgan- 
moxynil. Comai et al., Nature 317:741-744 (1985), Gordon- isms, plants, plant parts, and plant cells). In this regard, the 
Kamm et al., Plant Cell 2:603-618 (1990) and Stalker et al., invention allows for selection and screening of transformed 
Science 242:419-423 (1 988). host cells, intact organisms, and parts of organisms in the 
Other selectable marker genes for plant transformation are 55 same manner as for green fluorescent protein (GFP). See 
not of bacterial origin. These genes include, for example, U.S. Pat. Nos. 5,162,227 and 5,491,084 and PCT applica- 
mouse dihydrofolate reductase, plant 5-enolpyruvylshiki- tions WO 96127675, WO 97111094, WO 97141228 and WO 
mate-3-phosphate synthase and plant acetolactate synthase. 97142320, all of which are incorporated herein by reference. 
Eichholtz et al., Somatic Cell Mol. Genet. 13:67 (1987), In particular, 3,6-DCSA can be detected in transformed host 
Shah et al., Science 233:478 (1986), Charest et al., Plant 60 cells, intact organisms, and parts of organisms using con- 
Cell Rep. 8:643 (1990). ventional spectrophotometric methods. For instance, micro- 
Commonly used genes for screening presumptively trans- scopes can be fitted with appropriate filter combinations for 
formed cells include 0-glucuronidase (GUS), 0-galactosi- fluorescence excitation and detection. A hand-held lamp 
dase, luciferase, and chloramphenicol acetyltransferase. Jef- may be used for benchtop work or field work (see Example 
ferson, R. A,, PlantMol. Biol. Rep. 5:387 (1987), Teeri et al., 65 1). Fluorescence-activated cell sorting can also be 
EMBO J. 8:343 (1989), Koncz et al., Proc. Natl. Acad. Sci. employed. 3,6-DCSA is excited at a wavelength of 312-313 
USA 84: 131 (1987), De Block et al., EMBO J. 3:1681 nm, with a maximum emission wavelength of 424 nm. 
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"Parts" of organisms include organs, tissues, or any other Gruber et al., "Vectors for Plant Transformation" in Methods 
part. "Plant parts" include seeds, pollen, embryos, flowers, in Plant Molecular Biology and Biotechnology, Glick, B. R. 
fruits, shoots, leaves, roots, stems, explants, etc. and Thompson, J. E. Eds. (CRC Press, Inc., Boca Raton, 
Selection based on dicamba tolerance or dicamba degra- 1993) pp, 89-1 19, 
dation can be used in the production of dicamba-tolerant 5 
~ h ,  most widely utilized method for introducing an 
~ l an t s  or dicamba-degrading microorganisms, in which case expression vector into plants is based on the natural trans- 
the use of another selection marker may not be necessary. formation system of Agrobacterium. See, for example, 
Selection based on dicamba tolerance or dicamba degrada- Horsch et al., Science 227:1229 (1985). A. tumefaciens and 
tion can also be used in the production of transgenic cells or lo  A, rhizogenes are plant pathogenic soil bacteria which 
organisms that express other genes of interest. Many such genetically transform plant cells. The Ti and Ri plasmids of 
genes are known and include genes coding for proteins of A. tumefaciens and A. rhizogenes, respectively, cany genes 
and genes that agro- responsible for genetic transformation of the plant. See, for 
nomic traits on plants (see, e.g., PCT WO 97141228, the example, Kado, C. I., Crit. Rev. Plant. Sci. 10:l (1991). 
complete disclosure of which is incorporated herein by l5 Descriptions of Agrobacterium vector systems and methods 
reference). for Agrobacterium-mediated gene transfer are provided by 
The DNA constructs of the invention can be used to numerous references, including Gruber et al., supra, Miki et 
transform a variety of host cells, including prokaryotes and al., supra, Moloney et al., Plant Cell Reports 8:238 (1 989), 
eukaryotes. The DNA sequences coding for the dicamba- 20 and U.S. Pat. Nos. 4,940,838 and 5,464,763. 
degrading enZYme(s) and the selection marker, if a separate A generally applicable method of plant transformation is 
selection marker is used, may be on the same or different microprojectile-mediated transformation wherein DNA is 
DNA constructs. Preferably, they are arranged on a single carried on the surface of microprojectiles. The expression 
DNA construct as a transcription unit so that all of the vector is introduced into plant tissues with a biolistic device 
coding sequences are expressed together. Also, the gene(s) 25 that accelerates the micro~rojectiles to speeds sufficient to 
of interest and the DNA sequence(s) coding for the dicamba- Penetrate plant cell walls and membranes. Sanford et al., 
degrading enzyme(s), when dicmba-tolerance or dicamba Part. Sci. Technol. 5127 (19871, Sanford, J. C., 5ends 
degradation is being used as a selection marker, may be on Biotech. 6:299 (1988), Sanford, J. C., Physiol. Plant 79:206 (1990), Klein et al., Biotechnology 10:268 (1992). 
the same or different DNA constructs. Such constructs are 
30 Another method for physical delivery of DNA to plants is prepared in the same manner as described above. sonication of target cells. Zhang et al., Bio/Echnology 9:996 
prokaryotic and e u k a ~ O t i c  (1991). Alternatively, liposome or spheroplast fusion have 
microorganisms (e.g., bacteria (including Agrobacterium been used to introduce expression vectors into plants. 
tumefaciens andEscherichia coli), yeast (including Saccha- Deshayes et al., EMBO J., 4:2731 (1985), Christou et al., 
romyces cerevisiae) and other fungi (including Aspergillus 35 Proc Natl. Acad. Sci. USA 84:3962 (1987). Direct uptake of 
sp.), plant cells, insect cells, and mammalian cells. Prefer- DNA into protoplasts using CaCl2 precipitation, p o l ~ v i n ~ l  
ably, the host cell is one that does not normally degrade alcohol or ~ol~-L-ornithine have also been reported. Hain et 
dicmba, However, the present invention can also be used to al., Mol. Gen. Genet. 199:161 and et al., 
increase the level of dicamba degradation in host cells that Cell Physiol. 23:451 (1982). Electroporation of protoplasts 
40 and whole cells and tissues have also been described. Donn 
normally degrade dicamba. 
et al., In Abstracts of VIIth International Congress on Plant 
Thus, the "transgenic" cells and organisms of the inven- cell and ~i~~~~ culture IAPTC, ~ 2 - 3 8 ,  p, 53 (1990); 
tion include cells and organisms that do not normally D'Halluin et al., Plant Cell 4: 1495-1 505 (1 992) and Spen- 
degrade dicamba, but which have been transformed accord- cer et al., Plant Mol. Biol. 24:51-61 (1994). 
ing to the invention so that they are able to degrade this 45 Transgenic dicamba-tolerant plants of any type may be 
herbicide. The "transgenic" cells and organisms of the produced according to the invention. In particular, broadleaf 
invention also include cells and organisms that normally plants (including beans, soybeans, cotton, Peas, Potatoes, 
degrade dicamba, but which have been transformed accord- sunflowers, tomatoes, tobacco, fruit trees, and ornamental 
ing to the invention so that they are able to degrade more of plants and trees) that are known to be injured 
this herbicide or to degrade the herbicide more efficiently, 50 dicamba can be transformed so that they become tolerant to 
the herbicide. Other plants (such as corn, sorghum, small 
Methods of transforming prokaryotic and eukaryotic host grains, sugarcane, asparagus, and grass) which are currently 
cells are well known in the art. See, e.g., Maniatis et al., considered tolerant to dicamba can be transformed to 
Molecular Cloning: A Laboratory Manual, Cold Spring increase their tolerance to the herbicide. "Tolerant" means 
Harbor, N.Y. (1982), Sambrook et al., Molecular Cloning: A 55 that the transformed plants can grow in the presence of an 
Laboratory Manual, Cold Spring Harbor, N.Y. (1989); PCT amount of dicamba which inhibits the growth of untrans- 
WO 96123898 and PCT WO 97142320. formed plants 
For instance, numerous methods for plant transformation It is anticipated that the dicamba-degrading OxYgenases of 
have been developed, including biological and physical the invention can function with endogenous reductases and 
transformation protocols, See, for example, Miki et al,, 60 ferredoxins found in transgenic host cells and organisms to 
degrade dicamba. Plant chloroplasts are particularly rich in 
"Procedures for Introducing Foreign DNA into Plants" in 
reductases and ferredoxins. Accordingly, a preferred 
in and BiOtechnO1O~, embodiment for the production of transgenic dicamba-tol- 
G1ick, B. R. and J. E. Eds. (CRC Press, Inc.> erant plants is the use of a sequence coding for a peptide that 
~ o c a  p at on, 1993) pp. 67-88. In addition, vectors and in 65 will direct the dicamba-degrading oxygenase into chloro- 
vitro culture methods for plant cell or tissue transformation plasts ("a chloroplast targeting sequence"). DNA coding for 
and regeneration of plants are available. See, for example, the chloroplast targeting sequence is preferably placed 
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upstrcam (5') of the sequence coding for the dicamba- EXAMPLES 
degrading oxygenase, but may also be placed downstream 
(3') of the coding sequence, or both upstream and down- Example 1 
stream of the coding sequence. Exemplary chloroplast tar- 
geting sequences include the maize cab-m7 signal sequence 5 Purification And Characterization of the 
(see Becker et al., Plant Mol. Biol. 20:49 (1992) and PCT Colnponents of Dicamba 0-Demethylase of 
WO 97141228) and the pea glutathione reductase signal Pseudomonas maltophilia DI-6 
sequence (Creissen et al., Plant J. 2:129 (1991) and PCT 
WO 97141228). An alternative preferred embodiment is the 
~ ~ ~ h ~ d ~  and ~ ~ t ~ r i l ~ :  
direct transformation of chloroplasts using a construct com- 10 Bacterium and growth conditions, Pseudomonas malto- prising a promoter in to obtain philia, strain DI-6 (Kreuger, et al,, (1989) J, Agric, Food 
expression of the oxygenase in chloroplasts. See, e.g., PCT Chem,, 37:534-538) was isolated from a soil site persis- 
W0 95124492 and U.S. Pat. No. 5,545,818. Of tently contaminated with dicamba, The bacterium was pro- 
course, if a selected transgenic host cell or organism does not 15 vided by Douglas Cork of the Illinois Institute of produce sufficient endogenous reductase, ferredoxin, or Technology (Chicago, Ill.), and was maintained on reduced 
the host Or can be transformed so that it &loride (Kreuger, J, p,, (1989) ph,D, thesis, Illinois 
produces One Or both of these 
as as the Institute of Technology, Chicago, Ill.), supplemented with 
oxygenase. either dicalnba (2 mglml) or a mixture of glucose (2 mglml) 
In Yet another embodiment, the invention provides a 20 and Casamino Acids (2 mglml). The carbon sources were 
method of controlling weeds in a field where transgenic filter-sterilized and added to the after it was auto- 
dicamba-tolerant plants are growing. The method comprises claved. Solid media were prepared by the addition of 1% 
applying an effective amount of dicamba to the field to (wtivol) Gelrite (Scott Laboratories, West Warwick, R.I.). 
the weeds. Methods of dicamba and Chemicals and reagents, Dicmba, 3,6-DCSA, and [14c] 
amounts of dicamba effective to control various types of 25 dicamba (U-phenyl-i4c, 42,4 mCilmmol, radiochemical 
weeds are laown. See Crop Protection Reference, pages purity greater than 98%) were supplied by Sandoz Agro, Inc. 
1803-1821 & Press, In'., New (Des Plaines, Ill.). To increase solubility, the dicamba and York, N.Y., 11th ed., 1995). 3,6-DCSA stock solutions were prepared by titration with 
In another embodiment, the invention provides a method KOH to p~ 7.0, ~ 1 1  chemicals were purchased from Sigma 
of degrading dicamba present in a material, such as soil, 30 Chemical Co. (St. Louis, Mo.), unless otherwise stated. 
water, or waste products of a dicamba manufacturing f a d -  Superose 12, Mono Q, Q-Sepharose (Fast Flow) and Phenyl- 
ity. Such degradation can be accomplished using the Sepharose (CL-4B) column packings for the FPLC (fast 
dicamba-degrading enzymes of the invention. The enzymes liquid chromatography) apparatus were 
can be purified from microorganisms naturally expressing obtained from Pharmacia (Milwaukee, Wis.). Ampholyte pH 
them (see Examples 1 and 3) or can be purified from 35 4-6 and ampholyte pH 4-9 were purchased from Serva 
transgenic host cells producing them. If the enzymes are (Heidelberg, FRG). Acrylamide, 0-mercaptoethanol, N,N, 
used in such methods, then appropriate cofactors must also Nt,Nt-tetramethylethylenedimine (TEMED) and ammo- 
be provided (see Example 1). Effective amounts can be nium persulfate (APS) were from Bio-Rad Laboratories 
determined empirically as is known in the art (see Example (Hercules, Calif.). Thin layer chron~atography (TLC) plates 
1). Alternatively, transgenic ~rokaryotic and eukaryotic 40 were silica gel (250 pm thickness) with W 254 indicator, 
microorganisms can be used to degrade dicamba in such and were from J, T, Baker Chemical Co. (Phil- 
materials. Transgenic prokaryotic and eukaryotic microor- lipsburg, N.J.), 
ganisms can be produced as described above, and effective Enzyme assays, Dicamba O-demethylase activity was 
amounts can be determined empirically as is known in the assayed by measuring the formation of [i4c13,6-DCSAfrom 
art. 45 [14C]dicamba. Briefly, the activity in mixtures of enzyme 
Dicamba is introduced into the environment in large components was measured at 300 C, in a 300 
quantities on a continuing basis. The elimination of dicamba ,,,tion mixture containing 25 m~ potassium phosphate 
is dependent in large part on the action of enzyme systems buffer (pH 7.0), 10 mM M ~ C ~ , ,  0.5 mM NADH (beta- 
which are found in microorganisms inhabiting the soil and nicotinamide adenine dinucleotide, reduced form), 0.5 mM 
water of the planet. An understanding of these enzyme 50 ferrous sulfate, 50 pM cold dicamba, 2.5 pM [14c] dicamba 
systems, including dicamba-degrading O-demethylases and (the final specific activity of the radioactive dicamba was 1.9 
their three components, is important in efforts to exploit mciimmol), and different amounts of cell lysate or partially 
natural and genetically modified microbes for bioremedia- purified enzyme, ~ 1 1  enzyme assays during the final purifi- 
tion and the restoration of contaminated soil, water and other ,,tion steps were conducted in phosphate buffer because the 
materials. Thus, the dicamba-degrading enzymes, DNA 55 pH optimum for dicamba 0-demethylase activity was found 
molecules, DNA constructs, etc., of the invention can be to be in the mid range of phosphate buffers, and higher 
used as research tools for the study of dicamba degradation enzyme activity was observed with phosphate buffer corn- 
and bioremediation. pared to Tris-HC1 [tris(hydroxymethyl)aminomethane 
Finally, the dicamba-degrading enzymes of the invention hydrochloride] buffer at pH 7.0. Reactions were initiated by 
can be used in an assay for dicamba. A sample suspected of 60 the addition of the substrate, dicamba. At specific times, the 
containing dicamba is mixed with a dicamba-degrading reactions were stopped by adding 50 p1 of 5% (vollvol) 
0-demethylase or a combination of a dicamba-degrading H,S04. Dicamba and dicamba metabolites were then 
oxygenase, a dicamba-degrading ferredoxin and a dicamba- extracted twice with one volume of ether, and the extracts 
degrading reductase. Suitable assays are described in were evaporated to dryness. The efficiencies of recovery 
Examples 1 and 3. In particular, detecting or quantitating the 65 (means+standard deviations) for the extraction procedure 
fluorescence due to the generation of 3,6-DCSA makes for were 87%+2% for dicamba and 85%+3% for 3,6-DCSA 
a convenient assay. (Yang et al., Anal Biochem. 219:3742 (1994)). 
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[14c]dicamba and 14c-labeled metabolites were separated (wtlvol) saturation, with constant stirring. After 15 minutes 
by thin layer chromatography (TLC). The ether-extracted of stirring, the mixtures were centrifuged at 15 ,400~ g for 15 
dicamba and its metabolites were redissolved in 50 pl of minutes, and the precipitate was discarded. Additional solid 
ether prior to being spotted onto a TLC plate. The solvent ammonium sulfate was added to 70% (wtlvol) saturation, 
system for running the TLC was chloroform-ethanol-acetic 5 with constant stirring of the supernatant. After 15 min of 
acid (85:10:5 [vollvollvol]). The resolved reaction products stirring, the mixtures were centrifuged under the conditions 
were visualized and quantified by exposing the TLC plate to described above. The supernatant was discarded, and the 
a phosphor screen for 24 hours and then scanning the screen precipitate was resuspended in a minimal volume of buffer 
in a Phosphorlmager SF (Molecular Dynamics, Sunnyvale, A(20 mM Tris [pH 8.0],2.5 mM MgCl,, 0.5 mM EDTA, 5% 
Calif.). Estimates of the amount of radioactivity in a par- l o  (vollvol) glycerol, and 1 mM dithiothreitol). The 40%-70% 
ticular spot on the TLC plate were determined by comparing ammonium sulfate cut was then loaded onto a Phenyl- 
the total pixel count in that spot relative to a spot on the same Sepharose column (2.5 by 10 cm) connected to a FPLC 
plate containing a known amount of [14~]dicamba. One unit apparatus (Pharmacia) and eluted with a decreasing linear 
of activity was defined as the amount of enzyme that gradient of (NH4),S04 from 10% (wlv) to 0% (wlv). The 
catalyzes the formation of 1 nmol of 3,6-DCSA from 1s column was preequilibrated with buffer A containing 10% 
dicamba per minute at 30' C. Specific activities were based (wtlvol) ammonium sulfate. The flow rate was 1 mllmin. 
on the total protein concentration of the assay mixture. Protein concentrations were continuously monitored at A,,, 
The activity of the reductase component of dicamba during column elution. The column was washed with 120 ml 
demethylase was assayed by measuring reduction of 2,6- of bufferA containing 10% (wtlvol) ammonium sulfate until 
dichlorophenolindophenol (DCIP) with a Hitachi U-2000 20 baseline A,,, readings were obtained. Bound proteins were 
spectrophotometer. The reaction contained 0.5 mM NADH, eluted with a decreasing gradient of (NH4),S04 in buffer A 
0.2 mM FAD (flavin adenine dinucleotide), 50 pM DCIP, 20 [ lo  to 0% (wtlvol) (NH4),S04 in a total volume of 210 ml]. 
mM Tris buffer (pH KO), and 10-100 pl of enzyme sample Fractions of 2 ml were collected. Aliquots of 10 p1 were 
in a total volume of 1 ml. The change in absorbance at 600 taken from each fraction and added to the standard dicamba 
nm with time was measured at room temperature. Specific 25 0-demethylase assay mixture (see above), except that non- 
activity was calculated using an extinction coefficient at 600 radioactive dicamba was used as the substrate. Dicamba 
nm of 21.0 m ~ - l c m - l  for reduced DCIP. Specific activity 0-demethylase activity was detected by monitoring the 
was expressed as nmol DCIP reduced min-mg-l of protein. conversion of dicamba to the highly fluorescent reaction 
In addition, an in situ DCIP assay was used to detect and product 3,6-DCSA with a hand-held W lamp (312 nm, 
locate the reductase activity in protein preparations sepa- 30 Fotodyne) in a darkened room. 
rated on isoelectric focusing (IEF) gels. After electrophore- This procedure allowed resolution of dicamba O-dem- 
sis of the proteins on an IEF gel, lanes sliced from the gel ethylase into three pools containing the separated compo- 
were washed with 20 ml of cold 20 mM Tris-HC1 buffer (pH nents (designated components I, I1 and 111). Each component 
8.0). Low melting agarose was dissolved by heating in 10 ml was essential for dicamba 0-demethylase activity (see 
of 20 mM Tris-HC1 buffer (pH 8.0) at a final concentration 35 below). When a single component was assayed, the other 
of 1.5% (wlv). When the agarose cooled to near room two components were provided in excess. Fractions con- 
temperature, it was supplemented with 0.2 mM FAD, 50 pM taining a single type of activity were pooled (component I, 
DCIP, and 0.5 mM NADH. The assay mixture was poured fractions 128-145; component 11, unbound fractions 12-33; 
onto a glass plate and allowed to solidify. The gel piece was component 111, fractions 62-92). 
placed on top of the solidified reaction mixture and allowed 40 (i) Purification of component I. Fractions containing 
to set at room temperature for 15 minutes. If the gel slice component I activity (eluting from a Phenyl-Sepharose 
contained a protein with reductase activity, a colorless band column at 0 M (NH4),S04, fractions 128-145) were pooled 
of reduced DCIP was generated in the blue background of to provide a total volume of 34 ml. The pooled samples were 
DCIP. concentrated to 10 ml by centrifugation in a Centriprep-10 
Cell lysates. Cells were grown to an optical density at 550 45 device (Amicon) and then applied to a Q-Sepharose (Fast 
nm of 1.3 to 1.5 in liquid reduced chloride medium con- Flow) FPLC column (Pharmacia) (2.5 by 6 cm) equilibrated 
taining a mixture of glucose and Casamino Acids on a rotary with buffer A and washed with 80 ml of buffer A. Proteins 
shaker (250 rpm at 30' C.). The cells were harvested by bound to the column were eluted with a 100 ml linear 
centrifugation, washed twice with cold 100 mM MgCl,, and gradient of 0 to 0.6 M KC1 in buffer A at a flow rate of 1 
centrifuged again. Cell pastes were either used immediately 50 mllmin. Fractions were collected at 1.5 minute intervals. 
or quickly frozen in liquid nitrogen and stored at -80' C. At Those fractions exhibiting component I activity (fractions 
the time of enzyme purification, 25 g of frozen cells were 29-37) were pooled, dialyzed against buffer A overnight at 
thawed and resuspended in 50 ml of isolation buffer con- 4" C. and applied to a Mono Q HR 515 FPLC anion- 
taining 25 mM Tris buffer (pH 7.0), 10 mM MgCl,, and 0.5 exchange column in buffer A. Proteins were eluted at 1 
mM EDTA. Phenylmethylsulfonyl fluoride and dithiothrei- 55 mllmin by using a 50 ml gradient of increasing KC1 con- 
to1 were added to final concentrations of 0.5 mM and 1 mM, centration (0 to 0.5 M). Fractions showing component I 
respectively. After addition of 10 mg of lysozyme and 1 mg activity (fractions 19 to 25) were pooled and concentrated to 
of DNase, cells were stirred for 10 min on ice and broken by 0.4 ml by centrifugation in a Centricon-10 device. The 
sonication (model XL2020 sonicator; Heat Systems) on ice concentrated sample was then subjected to chromatography 
at a medium setting (setting 5) with twelve 20-second bursts 60 on a Superose 12 FPLC column (1.6 by 50 cm) at a flow rate 
and 40-second resting intervals. The resulting cell lysates of 0.2 mllmin with buffer A containing 100 mM KCl. 
were diluted to 90 ml with isolation buffer and centrifuged Fractions 7-10 showing component I activity were pooled 
at 76 ,000~ g for 1 h at 4" C. The supernatant was used as the and concentrated by centrifugation in a Centricon-10 device. 
source of cleared cell lysate. The partially purified component I was diluted with cold 
Enzyme purification. All procedures were performed at 4' 65 1% (wlv) glycine and concentrated by centrifugation in a 
C., unless otherwise stated. Solid ammonium sulfate was Centricon-10 device three more times to desalt it in prepa- 
slowly added to a 90-ml volume of cleared cell lysate to 40% ration for IEF electrophoresis. The desalted and concen- 
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trated sample was then applied to a 6% (wlv) IEF (pH 4-6) described above. The gel segment which showed component 
gel and subjected to electrophoresis for 1.5 hours at 4' C. I1 activity was loaded onto a 12.5% (wlv) SDS-PAGE for 
(see below). After electrophoresis, the gel was washed with further analysis. 
25 mM cold phosphate buffer (pH 7.0) for 5 minutes and Determination of NH,-terminal amino acid sequences. 
then each slice of the gel lane was diced into small (6 mmx4 5 Protein bands were excised from IEF gels and placed in the 
mm) pieces. Protein was eluted from the diced gel fragments wells of a 12.5% (wlv) SDS polyacrylamide gel. After 
by grinding them with a pipette tip in the presence of 10 p1 electrophoresis, the gel slices containing the purified pro- 
of 25 mM phosphate buffer (pH 7.0). Protein from each teins were transblotted onto a PVDF (polyvinylidene dif- 
segment was mixed with an excess of components I1 and I11 luoride) membrane (Millipore) in a Trans-Blot cell (Bio- 
and assayed for dicamba 0-demethylase activity. The gel l o  Rad, Richmond, Calif.) at 25 volts for 16 hours. The blotting 
segment which showed component I activity (which was buffer was a solution of 20% (vlv) methanol with 10 mM 
also reddish brown in color) was loaded onto a 12.5% (wlv) CAPS [3-(cyclohexylamino)-1-propanesulfonic acid], pH 
sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) to 10.0. Sequencing was performed using an Applied Biosys- 
check sample purity. tems Inc. 420 H machine by Edman degradation (Edman and 
(ii) Purification of component 11. Component I1 obtained 1s Henschen (1975) pages 232-279 in S. B. Needleman (ed.), 
by Phenyl-Sepharose column chromatography was dialyzed Protein sequence determination, 2nd ed., Springer-Verlage, 
against buffer A overnight at 4' C. and applied to a FPLC New York). 
Q-Sepharose column (2.5 by 6 cm). Sample elution condi- Determination of protein concentration. Protein concen- 
tions were identical to those described above for component trations were determined by the method of Bradford (1 976) 
I except that the elution gradient was 0 to 1 M KC1 in buffer 20 Anal. Biochem. 72:248-254, with bovine serum albumin as 
A. Fractions exhibiting component I1 activity (fractions the standard. 
30-37) were pooled, dialyzed against buffer A, concentrated SDS-PAGE. Sodium dodecyl sulfate-polyacrylamide gel 
to 0.4 ml and applied to a FPLC Superose 12 column (1.6 by eletrophoresis (SDS-PAGE) was performed according to 
50 cm). The procedures for sample application and elution modified methods of Laemmli (Laemmli (1970) Nature, 
were identical to those described above for component I. 25 227:680-685). 12.5% (wlv) SDS gels of 8 5 ~ 6 5 ~ 0 . 7 5  mm 
Fractions exhibiting component I1 activity (fractions 3-6) were made as follows: running gel: 2.5 ml 40% (wlv) 
were pooled, diluted with an equal volume of buffer A, and acrylamidelbis solution (37:5: I), 1 ml running buffer solu- 
applied to a FPLC Mono Q column. Proteins were eluted tion [3M Tris-HC1 (pH 8.8), 0.8% (wlv) SDS], 4.5 ml H,O, 
from the column using the same KC1 gradient as for com- 5 p1 TEMED, and 40 p1 10% (w1v)APS; stacking gel: 0.5 ml 
ponent I. Fractions 20-25 showed component I1 activity. 30 40% (wlv) acrylamideibis, 0.5 ml stacking buffer solution [I 
Partially purified component I1 was further purified by IEF M Tris-HC1 (pH 6.8), 0.8% (wlv) SDS], 3 ml H,O, 5 p1 
(pH 4-6) electrophoresis using the same conditions as TEMED, and 12.5 p1 10% (wlv) APS. The composition of 
described for component I. The gel segment which showed the running buffer was 25 mM Tris-HC1 (pH 8.3), 0.2 M 
component I1 activity was loaded onto a 12.5% (wlv) glycine, and 0.1% (wlv) SDS. The sample buffer contained 
SDS-PAGE for further analysis. 35 0.25 ml stacking buffer, 0.6 ml 20% (wlv) SDS, 0.2 ml 
(iii) Purification of component 111. Component I11 0-mercaptoethanol, and 0.95 ml 0.1% bromphenol blue 
obtained by Phenyl-Sepharose column chromatography was (wlv) in 50% (vlv) glycerol. Electrophoresis was performed 
dialyzed against buffer A overnight at 4' C. and applied to at 80 volts in a Bio-Rad Mini Gel apparatus until the 
a FPLC Q-Sepharose column (2.5 by 6 cm). Conditions tracking dye was 0.5 cm from the anode end of the gel. 
were identical to those described above for component I. 40 Proteins were stained with 0.1% (wlv) Coomassie Brilliant 
Fractions exhibiting component I11 activity (fractions Blue R-250 in a mixture of isopropanol, water, and acetic 
26-38) were dialyzed against buffer B [ lo  mM Tris-HC1 (pH acid at a ratio of 3:6: 1 (vlvlv). Destaining was performed in 
7.5), 2.5 mM MgCl,, 5% (vlv) glycerol, 1 mM dithiothrei- a mixture of methanol, water, and acetic acid at a ratio of 
toll and concentrated to 5 ml. Blue dye affinity matrix 7:83:10 (vlvlv). Standard proteins (Gibco BRL) included: 
[Cibacron Blue 3GA type 3000 (Sigma)] was packed into a 45 myosin (214.2 kDa), phosphorylase B (111.4 m a ) ,  bovine 
FPLC column (1x5 cm) and pre-equilibrated with 20 ml of serum albumin (74.25 kDa), ovalbumin (45.5 m a ) ,  carbonic 
buffer B. Concentrated component I11 was loaded onto the anhydrase (29.5 kDa), 0-lactoglobulin (18.3 kDa), and 
blue dye column and washed with 20 ml of buffer B at a flow lysozyme (1 5.4 kDa). 
rate of 0.2 mllmin until the A,,, of the column effluent Determination of molecular weight. The molecular 
reached baseline levels. Bound protein was then eluted with 50 weight (M,) of peptides under denaturing conditions was 
5 mM NADH in buffer B. Fractions containing reductase estimated using SDS-PAGE analysis. The molecular weights 
activity were detected by assaying for dicamba 0-demethy- of the native components I, I1 and I11 were estimated by gel 
lase activity in the presence of an excess of components I filtration through a Superose 12 HR 10130 FPLC column 
and I1 and also by the ability of each fraction to reduce DCIP (Pharmacia) at a flow rate of 0.2 mllmin in buffer A 
in the presence of NADH. Fractions having strong reductase 55 containing 100 mM KCl. Calibration proteins were gel 
activity in both assays were pooled, dialyzed against buffer filtration standards from Bio-Rad. They were: bovine thy- 
A containing 100 mM KCl, concentrated to 0.2 ml, and roglobulin (670 kDa), bovine gamma globulin (158 kDa), 
applied to a FPLC Superose 12 column. The same condi- chicken ovalbumin (44 kDa), horse myoglobin (17 kDa) and 
tions were used for running the Superose column as vitamin B-12 (1.35 kDa). The void volume of the Superose 
described for component I. Fractions containing proteins 60 12 column was calculated using Blue Dextran (M, 2,000, 
which catalyzed DCIP reduction were pooled, dialyzed 000, Sigma). 
against buffer A and applied to a FPLC Mono Q column. IEF. Isoelectric focusing (IEF) gel electrophoresis was 
Proteins were eluted using the same conditions as for performed in a vertical mini-gel apparatus (Model #MGV- 
component I. Partially purified component I11 was further 100) from C.B.S. Scientific Co. (Del Mar, Calif.). IEF gels 
purified by IEF (pH 4-6) gel electrophoresis. The reductase 65 with 6% (wlv) polyacrylamide (70x90~1 mm) were made 
activity of proteins within the IEF gel was detected by by mixing the following: 1.6 ml 30% (wlv) acrylamideibis 
assaying for DCIP reduction in an agarose gel overlay as (37:5:1), 0.8 g glycerol, 0.32 ml ampholyte pH 4-6 (Serva), 
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0.08 ml ampholyte pH 4-9 (Serva), 5.2 ml H20, 10 p1 [14~]dicamba under anaerobic conditions was significantly 
TEMED, and 80 pl 10% (wlv) APS. The cathode buffer was is lower than the rate of reactions with the same amount of 
100 mM 0-alanine and the anode buffer was 100 mM acetic enzyme under aerobic conditions. Under anaerobic condi- 
acid. Protein samples in approximately 1 to 10 of 1% tions, there was virtually no conversion of dicamba to 
(wlv) glycine were mixed with an equal volume of sample 5 3,6-DCSA within 1 hour. However, when a parallel reaction 
buffer [50% (vlv) glycerol, 1.6% (vlv) a m ~ h o l ~ t e  PH 4-9, mixture was taken from the anaerobic chamber after 30 min 
2.4% a m ~ h O 1 ~ t e  pH 4-61. were loaded at the and incubated with air, a significant quantity of one of the 
cathode end of the gel and allowed to migrate at 200 volts of the dicamba O-demethylase enzyme com- 
for 1.5 hours and 400 volts for another 1.5 hours. Proteins plex was a oxygenase, may be noted that the in vitro 
were stained with Coomassie Brilliant Blue R-250 using the l o  conversion of [14c]dicamba to [ ~ ~ c ] ~ , ~ - D c s A  mimics the 
procedure described above for SDS ~ol~acrylamide g ls. in viva conversion pathway documented earlier (Cork and 
IEF markers (Sigma) were: am~lOglucOsOdase, PI 3.6; glu- Kreuger, Adv. Appl, Microbial, 3611-66 (1991); Yang et al., 
cose oxidase, PI 4.2; trypsin inhibitor, pI 4.6; fl-lactoglobulin Anal, Biochem. 219:37-42 (1994)). In these studies, DCSA 
A, PI 5.1; carbonic d y d r a s e  11, PI 5.4; carbonic d y d r a s e  was identified as a reaction product by both TLC and 
11, pI 5.9 and carbonic anhydrase I, pI 6.6 l5 capillary electrophoresis. Stringent identification of the first 
Kinetic analysis. The kinetics of the demethylation reac- 
,,jar product ofdicamba degradation as D C S A ~ ~ ~ ~  in viva 
tion catalyzed by dicamba O-demeth~lase were studied by and in vitro has been obtained by gas chromatography-mass 
analyzing the initial rates of the reaction in the presence of spectrometry analyses, 
a constant concentration of the enzyme and increasing Component and cofactor requirements. After the initial 
concentrations of the substrate, dicamba. Reaction mixtures 20 
contained 25 mM potassium phosphate buffer (pH 7.0), 10 separation of the three components of dicamba O-demethy- lase by phenyl-Sepharose column chromatography, the par- 
mM MgC12' 0'5 mM NADH' 0'5 mM FeS04' 25 pg of tially purified preparations were taken individually through partially purified O-demethylase enzyme [the 40%-70% 
one additional purification on a Q-Sepharose column (2.5 by (wlv) (NH4),S04 fraction from a cleared cell lysate], various 6 cm). Samples were applied to a Q-Sepharose (Fast Flow) 
concentrations (0.5 to 50 pM) of dicamba and various 25 fast protein liquid chromatography column (Pharmacia) in 
concentrations (0.025 to 2.5 pM) of [14C]dicamba (U-phe- buffer A and eluted with a 100-ml linear gradient of 0 to 0.6 
nyl-14c, 42.4 mcilmmol) in a total volume of 300 pl. For 
assays with dicamba concentrations of 0.5 pM and 1 pM, the M KC1 (for the oxygenase component) or 0 to 1.0 M KC1 (for the ferredoxin and reductase components) in 1.5-ml 
reaction volume was increased to 900 p1 to ensure that fractions. Appropriate pooled fractions from separate col- 
sufficient amounts of radioactive dicamba and its metabo- 30 
umns for oxygenase purification (fractions 29 to 37), for lites were present to allow detection. In these reactions, the ferredoxin purification (fractions 30 to 37), or for reductase 
amounts of all other components in the reaction were tripled. 
The conversion of [14C]dicamba to [14C]3,6-DCSA was purification (fractions 26 to 38) were used for the determi- 
nation of component and cofactor requirements. determined for different time points at each concentration of 
dicamba using a PhosphorImager SF to scan radioactivity on 35 The three were assayed for O-demethylase 
phosphor screens which had been exposed to TLC plates for activity in various combinations to determine component 
24 hours. One unit of activity was defined as the amount of requirements. 
enzyme that forms 1 mmol of 3,6-DCSA per minute at 30' To determine cofactor requirements, O-demethylase 
C. The initial rates of each reaction were determined by activity was assayed using a mixture of the three compo- 
plotting the reaction rate versus time at each substrate 40 nents with [14Cldicamba for 30 minutes at 30' C. The 
concentration. Data were modeled to Michaelis-Menten amounts of partially purified protein (provided in an opti- 
kinetics and values of K, and V, were determined by mized ratio) in the reaction mixtures were 85 pg of oxyge- 
fitting to Lineweaver-Burk plots using SigmaPlotB (Jandel nase, 55 pg of ferredoxin and 50 pg of reductase. The 
Scientific, Corte Madera, Calif.). concentration of cofactors used in the reaction mixtures 
Oxygen requirement. Preliminary experiments using a 45 were 0.5 mM NADH, 0.2 mM FAD, 0.5 mM FeSO,, 10 mM 
Clark oxygen electrode indicated oxygen consumption dur- MgC12, 0.5 mM NADPH, and 0.2 mM FMN. 
ing a standard dicamba O-demethylase assay with dicamba 
as a substrate. To verify a requirement for oxygen in the 0 
demethylation of dicamba by dicamba O-demethylase, reac- Component 1. The component of dicamba O-demeth~lase 
tions were conducted in an anaerobic chamber which con- 50 which bound most tightly to the Phen~l-Se~harose column 
tained less than 1 ppm of oxygen, l-he procedures for (designated initially as component I and subsequently iden- 
displacement of oxygen from the mixture were tified as an oxygenase) was distinctly reddish brown in color. 
performed at 40 C,  ti^^ mixtures lacking enzyme were This indicated the potential presence of a protein(s) con- 
placed in a vial and sealed with a rubber stopper. For taining an iron-sulfur cluster(s) or a heme grou~(s). The 
displacement of oxygen, the vial was evacuated twice by 55 fractions with component I activity from the Phenyl- 
vacuum and flushed each time with nitrogen. After a third Se~harose column were subjected to further purification by 
evacuation, the vial was flushed with 90% nitrogen plus 10% Q-Se~harose (Fast Flow) and Mono Q chromatography and 
hydrogen, l-he enzyme solution was likewise purged of then to separation on a Superose 12 size exclusion column. 
oxygen (with care taken not to bubble the enzyme solution). The component I protein was then further purified on an IEF 
Both the reaction mixtures and enzyme solutions were 60 gel. 
transferred into an anaerobic chamber (95% N2-5% Hz Protein from the major band on the IEF gel (with an 
atmosphere). Two hundred forty microliters of cleared cell apparent pI of approximately 4.6) was excised and separated 
lysate was injected through the rubber stopper with a from any remaining minor contaminants by SDS-PAGE. 
microsyringe and gently mixed with 960 p1 of oxygen-free The major component I protein obtained after purification by 
reaction mixture. Reactions were carried out at 30' C. 65 IEF was greater than 90% pure as judged by densitometric 
An examination of the reaction products on TLC plates analysis of this SDS-polyacrylamide gel stained with Coo- 
showed that the rate of [ 1 4 c ] 3 , 6 - ~ c s ~  production from massie Blue. 
The N-terminal amino acid sequence of the dominant 
protein with an apparent molecular mass of approximately 
40,000 Daltons was determined. Results of amino acid 
sequencing indicated that the first 29 amino acids of the 
N-terminal region were present in the following sequence 
(residues in parentheses are best guesses): 
Thr Phe Val Arg Asn Ala Trp Tyr Val Ala Ala Leu Pro Glu 
Glu Leu Ser Glu Lys Pro Leu Gly Arg Thr Ile Leu Asp (Asp 
or Thr) (Pro) 
[SEQ ID N0:l l .  
NADH. Neither component I nor component I1 showed 
activity in either of these two reductase assays. 
Additional purification of this fraction by chromatogra- 
phy on columns containing Q-Sepharose (Fast Flow), blue 
5 dye affinity matrix, Superose 12, and Mono Q packings 
resulted in low amounts of protein in the fractions with 
reductase activity. The component I11 protein was about 70% 
pure as judged by densitometric analysis of the active 
protein fraction after separation by SDS-PAGE and staining 
l o  with Coomassie Blue. 
- .  
To further exacerbate purification of component 111, it was Comparison with amino acid sequences in various databases found that two different protein fractions from the M~~~ Q 
indicated little or no homology with NHz-terminal column step contained reductase activity when assayed with 
sequences reported for mOnoxygenases Or diOx~gena- the ferredoxin and oxvaenase comvonents. Further vurifi- 
. - 
ses. 15 cation of these two fractions by eletrophoresis on an IEF gel 
I1. The protein which did bind revealed that the reductase activities of the two fractions had 
a Phenyl-SepharOse was designated as distinctly different isoelectric points. This was demonstrated 
11. Because this yellowish colored fraction could be replaced by excising lanes containing each of the two reductase 
ferredOxin C1ostridium pasteurianum (but with fractions from the IEF gel and laying the slices on top of a 
rates) when assays were performed in 20 pad of low melt agarose containing a DCIP reaction mixture. 
bination with components I and 111, it was tentatively 
~~d~~~~~~ activity in both gel slices was identified by the 
designated as a ferredoxin-containing fraction. The N A D H - ~ ~ ~ ~ ~ ~ ~ ~ ~  reduction of DCIP to its colorless, 
Clostridium ferredoxin clearly functioned in place of com- reduced form, ne reductase in fraction 35 had an apparent 
POnent 11, but given the nature the pI of approximately 5.6 while the reductase in fraction 27 
ponent I1 used in these experiments, the efficiency of the 25 possessed an apparent p~ of approximately 4.8, 
C1ostridium enzyme was lower than that the Both reductase activities isolated from the IEF gel slices 
putative ferredOxin from strain D1-6. In particular, 55 pg were unstable and present in low amounts. Indeed, only the 
partially purified I1 mixed with excess reductase from fraction 35 from the Mono Q column frat- 
of components I and 111 catalyzed the conversion of dicamba tionation retained sufficient protein concentration and 
3,6-DCSA at a rate 
nmO1 min-'mg-', 30 ity to allow further purification and characterization. A slice 
loo pg purified ferredoxin C1ostridium from an IEF gel containing this reductase activity was eluted 
resulted in an activity of only 0.6 nmol min-'mg-'. and separated from contaminating proteins by SDS-PAGE. 
hrification steps involving Q-Se~harose (Fast Flow) The predominant protein in this gel was one with a mass of 
chromatography, Su~erose 12 gel filtration and Mono Q approximately 45,000 Daltons. Size exclusion chromatog- 
chromatography yielded approximately one milligram of 35 raphy had indicated an approximate molecular mass of 
purified protein from an initial 25 grams of cell paste. This 50,000 ~ ~ l t ~ ~ ~  for component 111 in its native state, 
fraction was purified in a similar manner to the oxygenase 
~ i ~ ~ h ~ ~ i ~ ~ l  characteristics of dicamba 0-demethylase, 
component by electro~horesis on an IEF gel and subsequent Dicamba 0-demethylase activity was measured during incu- 
electrophoresis of the active IEF fraction on an SDS- bations in vitro at temperatures ranging from 200 C, to 500 
polyacrylamide gel. 40 C. and at pH values from approximately 6 to 9. Activity 
Analysis of component 11 activity in proteins eluted from peaked sharply at 30° C. and broadly at pH values between 
segments of the IEF gel indicated that a fraction with a pI of 6.5 and 7.5. Enzymatic activity was dependent on the type 
approximately 3.0 contained the active protein in component of pH buffer employed. At pH 7, for example, activity was 
11. Protein from this gel slice was eluted and subjected to approximately 40% lower in Tris-containing buffers than in 
SDS-PAGE. Staining of the gel with Coomassie Blue 45 phosphate-containing buffers. 
revealed one prominent band of protein (molecular weight Values for K, and V, for dicamba 0-demethylase were 
of about 28,000 Daltons) along with a smear of lower estimated using SigmaPlotB to generate best fit curves from 
molecular weight proteins. Michaelis-Menten and Lineweaver-Burk plots of data from 
Component 111. Component I11 of dicamba 0-demethy- duplicate experiments. The K, for dicamba was estimated to 
lase was retained on a Phenyl-Sepharose column in high 50 be approximately 9.923.9 pM and the V, for the reaction 
concentrations of (NH4),S04 and eluted at approximately was estimated to be approximately 108212 nmollmidmg. 
4% (wlv) (NH4),S04. This light yellow fraction was tenta- The three components were assayed for dicamba 0-dem- 
tively identified as a reductase-containing fraction based on ethylase activity in various combinations. None of the 
its ability to reduce oxidized cytochrome c and DCIP in the components showed enzyme activity when assayed alone. 
presence of NADH and because it could be replaced by 55 Indeed, a significant amount of 0-demethylase activity 
cytochrome c reductase from porcine heart (Type 1, Sigma) could be detected only when all three components were 
in assays with components I and 11. In this set of reactions, combined. Amixture of components I and I1 exhibited small 
the use of 50 pg of partially purified component I11 produced amounts of enzyme activity, probably due to traces of 
a reaction rate of approximately 5 nmol min-'mg-' when component I11 contaminating the component I fractions. 
mixed with an excess of components I and 11. The highly 60 Both NADH and NADPH supported enzyme activity, 
purified cytochrome c reductase showed a specific activity with NADH being markedly more effective than NADPH. 
of approximately 2.5 nmol min-'mg-' in the reaction, an Mg2+ was necessary for enzyme activity. ~ e " ,  flavin 
activity well below that provided by component I11 when adenine dinucleotide (FAD), and flavin mononucleotide 
one considers the impurity of the crude component I11 used (FMN) produced little or no stimulation of enzymatic activ- 
in these assays. In addition, component I11 exhibited reduc- 65 ity with the partially purified protein preparations in these 
tase activity when incubated with cytochrome c or 2,6- experiments. The highest activity was obtained using a 
dichlorophenol-indophenol (DCPIP) in the presence of combination of NADH, ~e" ,  Mg2+, and FAD. 
Discussion as a dimer in its native state. This (a),-type subunit arrange- 
Dicamba 0-demethylase from Pseudomonas maltophilia, ment is similar to that found in other well characterized 
strain DI-6, is a three component oxygenase (Wang, X-Z oxygenases such as 4-chlorophenylacetate 3,4-dioxygenase 
(1996) Ph.D. thesis, University of Nebraska-Lincoln, Lin- from Pseudomonas sp. strain CBS (Markus, et al. (1986) J. 
coln, Nebr.) responsible for the conversion of the herbicide, 5 Biol. Chem. 261:12883-12888), phthalate dioxygenase from 
dicamba (2-methoxy-3,6-dichlorobenzoic acid), to 3,6- Pseudomonas cepacia (Batie, et al. (1987) J. Biol. Chem. 
dichlorosalicylic acid (3,6-DCSA; 2-hydroxy-3,6-dichlo- 262: 15 1 6 1  51 8), 4-sulphobenzoate 3,4-dioxygenase from 
robenzoic acid). Purification schemes have been devised Comamonas testosteroni (Locher, et al. (1991) Biochem. J,  
which have allowed the isolation of each of the three 274:833-842), 2-0x0-1,2-dihydroquinoline X-monooxyge- 
components to a homogeneous or near-homogeneous state. 10 nase from Pseudomonas putida 86 (Rosche et al. (1995) 
Initial separation of the three components was achieved Biochem. Biophys. Acta 1252:177-179), 4-carboxydiphenyl 
by chromatography on a Phenyl-Sepharose column. Enzy- ether dioxygenase from Pseudomonas pseudoalcaligenes 
matic activities and other characteristics of the partially (Dehmel, et al. (1995) Arch. Microbiol. 163:35-41), and 
purified components allowed a tentative identification of the 3-chlorobenzoate 3,4-dioxygenase from Pseudomonas 
components as a reductase, a ferredoxin and an oxyge- 1s putida, (Nakatsu, et al. (1995) Microbiology (Reading) 
nase-a composition similar to that found in a number of 141:485495). 
other previously studied heme-containing and nonheme- FerredoxinDrc. Component I1 (ferredoxin,,,) of dicamba 
containing, multicomponent oxygenases (Batie, et al. (1 992) 0-demethylase was purified by several steps of column 
pages 543-565, In F. Miiller (ed.), Chemisty and biochem- chromatography and IEF. Final purification by SDS-PAGE 
istry of javoenzymes, vol. 111, CRC Press, Boca Raton; 20 produced one major band of protein (M, -28,000) and a 
Harayama, et al. (1992) Annu. Rev. Microbiol. 46:565-601; smear of slightly smaller proteins. 
Mason and Cammack (1992) Annu. Rev. Microbiol. The N-terminal amino acid sequence of the protein with 
46:277-305; Rosche et al. (1995) Biochem. Biophys. Acta an apparent molecular weight of approximately 28,000 
1252:177-179). Component I11 isolated from the Phenyl- Daltons was determined. This amino acid sequence permit- 
Sepharose column catalyzed the NADH-dependent reduc- 25 ted the preparation of degenerate oligonucleotide probes, 
tion of both cytochrome c and the dye, DCIP. In addition, its and these probes were used to isolate a genomic clone 
ability to support conversion of dicamba to 3,6-DCSA when coding for this protein. Although the protein produced by 
combined with components I and I1 could be replaced in part this clone was a ferredoxin (ferrodoxin,,,,, it was subse- 
by cytochrome c reductase. Component I1 could be replaced quently determined not to be active in the degradation of 
bv the addition of ferredoxin from Clostridium aasteur- 30 dicamba when combined with the other two comvonents of 
ianum to reactions containing components I and 111. The dicamba 0-demethylase (data not shown). 
absolute need for molecular oxygen to support the 0-dem- Other evidence supports the conclusion that 
ethylation reaction indicated that the remaining component f e r r o d o ~ i n ~ ~ ~ ~ ~  is not the ferredoxin component of dicamba 
was an oxygenase. 0-demethylase. First, the molecular mass of this protein (28 
Oxygenase,,,. Component I of dicamba 0-demethylase 35 kDa) protein is significantly higher than that of the other 
(designated as oxygenaseDrc) has been purified to homoge- ferredoxins found in multicomponent oxygenases from bac- 
neity and subjected to N-terminal amino acid sequencing. teria (i.e., 8-13 kDa) (Batie, et al. (1992) pages 543-565, In 
The resulting sequence of twenty nine amino acid residues F. Miiller (ed.), Chemistry and biochemistry of javoen- 
showed no significant homology to other protein sequences zymes, vol. 111, CRC Press, Boca Raton; Harayama, et al. 
in the various data banks. However. the information 40 (1992) Annu. Rev. Microbiol. 46:565-601). 
, , 
obtained from this amino acid sequence permitted the design Second, a comparison of the N-terminal sequence of 20 
of degenerate oligonucleotide probes which have been suc- amino acid residues obtained from ferredoxin,,,, to other 
cessfully used to detect and clone the component I gene (see amino acid sequences in the various protein data banks using 
Example 2). Furthermore, a comparison of the amino acid Genetics Computing Group (GCG) software package (Uni- 
sequence derived from the nucleotide sequence of this clone 45 versity of Wisconsin, Madison, Wis.) revealed strong 
with that of the protein sequences in the data base showed homology (80-85% identity compared to the most likely 
strong homology to other oxygenases (see Example 2). N-terminal sequence of ferredoxin,,,, to a number of 
The apparent molecular mass of oxygenase,,,, estimated dicluster bacterial ferredoxins (those from Pseudomonas 
from its migration in SDS-polyacrylamide gels, is approxi- stutzeri, Pseudomonas putida, Rhodobacter capsulatus and 
mately 40,000 Daltons. Purified preparations of the oxyge- 50 Azotobacter vinelandii). The four dicluster ferredoxins 
nase exhibited only one major band on SDS-polyacrylamide which showed strong homology to ferredoxin,,,, have a 
gels stained with Coomassie Blue and Edman degradation of [3Fe-4S] cluster followed by a [4Fe-4S] cluster at the 
the protein contained in that band indicated the presence of N-terminus of the protein. This suggests that ferredoxin,, 
only one N-terminal species. Estimates derived from the kDa is distinctly different from the ferredoxin components 
behavior of native oxygenase,,, on size exclusion columns 55 with [2Fe-2S] clusters which are usually associated with 
suggests a molecular size of approximately 90,000 Daltons. non-heme multicomponent oxygenases (Harayama, et al. 
All of these results suggest that the native oxygenase exists (1992) Annu. Rev. Microbiol. 46:565-601; Mason and Cam- 
as a homodimer. mack (1992) Annu. Rev. Microbiol. 46:277-305; Rosche, et 
The oxygenaseihydroxylase component of a number of al. (1995) Biochem. Biophys. Acta 1252:177-179). 
multicomponent systems is composed of an (afl),-type 60 ReductaseDrc Component I11 of dicamba 0-demethylase 
subunit arrangement in which the larger a subunit is (designated as reductase,,) has been the most recalcitrant 
approximately 50,000 Daltons in size and the smaller fl  of the three components% purify. This is due in part to its 
subunit is approximately 20,000 Daltons in molecular mass apparent instability and low abundance in lysates of strain 
(Harayama, et al. (1992) Annu. Rev. Microbiol. DI-6. Nonetheless, sufficient protein has been purified to 
46:565-601). In contrast, the oxygenase component of 65 assign a tentative molecular mass of 45,000 Daltons. This is 
dicamba 0-demethylase appears to possess a single subunit similar to the molecular mass of approximately 50,000 
of approximately 40 kDa in molecular mass which may exist Daltons obtained from size exclusion chromatography and 
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suggests that reductaseDrc exists in its native form as a Thr Phe Val Arg Asn Ala Trp Tyr Val Ala Ala Leu Pro Glu 
monomer. The purification of the reductase component has Glu Leu Ser Glu Lys Pro Leu Gly Arg Thr Ile Leu Asp (Asp 
been further complicated by the fact that chromatography on or Thr) (Pro) 
a Mono Q column and IEF resolves purified reductase [SEQ ID NO: 11. 
preparations into two activities with apparently distinct pI 5 This sequence permitted the design of degenerate oligo- 
values. Both fractions from the Mono Q column functioned nucleotide probes which were synthesized by Operon, 
in with purified ferredoxinDrc and oxygena- Alameda, Calif. In particular, a mixture of 32 probes, each 
seDrc to produce dicamba 0-demethylase activity, l-he pres- of which was 17 nucleotides in length, and contained all of 
ence in ~~h~~~~~~~~~ sp, strain R W ~  of two similar fla- the possible nucleotide sequences which could encode the 
voproteins which function equally well as reductase 10 amino acid sequence highlighted in bold above, was used. 
components in the three component dibenzofuran 4,4a- The oligonucleotide probes were 3'-end-labeled with digoxi- 
dioxygenase has recently been reported by Bunz and Cook genin provided Bee- 
(Biinz and Cook (1 993) J. Bacteriol. 175:6467-6475). Inter- lvinger Mannheim, Indianapolis, Ind. 
estingly, both reductases were 44,000 Daltons in molecular The probes were first hybridized ' 
mass, quite similar to that of the 45,000 Dalton reductased- 15 tophilia DI-6 genomic DNA which had been digested with 
,. ~ ~ l ~ i ~ l ~  components of leghemoglobin reductase have various combinations of restriction enzymes, resolved on a 
also been observed in lupin root nodules using isoelectric 1% agarose gel, and blotted to a nylon filter. Based on these 
focusing techniques ( T ~ ~ ~ ~ ~ ~ ,  et al, (1982) ~ i ~ k h i ~ i ~ ~  results, a size-fractionated genomic library was constructed 
(English edition) 162:378-379). In this case, IEF revealed in the pBluescript I1 KS+ and transformed 
four separate components with NADH-dependent reductase 20 Escherichia coli DH5a The genomic 
activity. The resolution of the question of whether there is library kb XhO IiHind II1 fragments. The 
only one reductaseDrc which exists in two forms or two DIG-labeled oligonucleotide probes were hybridized to an 
distinct reductases in strain DI-6 will rely on the develop- array of bacterial colonies streaked on nylon filters. Plasmid 
merit of improved procedures for isolating larger quantities DNA was isolated from positive colonies and subcloned. 
of the proteins and/or on the cloning and sequencing of the 25 Both strands of each subclone were sequenced by the DNA 
gene(s) involved (see Examples 3 and 5). Sequencing Facility at the University of Nebraska-Lincoln. 
Hybridization and detection of DIG-labeled probes were Dicamba 0-demethylase characteristics. In addition to the performed according to protocols provided by Boehringer physical and biochemical properties of the individual com- 
ponents noted above, analyses of enzymatic activity have Mannheim. 
30 A genomic DNA clone coding for the oxygenase,,, was 
shown that the 0-demethylase system has a strong affinity identified. The nucleotide sequence and the deduced amino (K,=-10 pM) for its substrate and a V, of approximately 
acid sequence of the entire oxygenase,,, are given in the 106110 nmollmidmg. As expected for a soil bacterium 
collected in a temperate climatic zone, the maximal enzy- Sequence Listing below as SEQ ID NO:2 and SEQ ID NO:3, 
respectively. 
matic activity was observed at temperatures near 30" C. 
35 A comparison of the amino acid sequence derived from While the pH optima for the enzyme system was in the range the nucleotide sequence of this clone with that of the protein from pH 6.5 to pH 7.5, the activity measured with a given 
sequences in the Swiss Protein Database showed homology preparation of enzyme was strongly affected by the type of to other oxygenases. Homology was determined using the pH buffering system employed. Activity in the presence of 
Tris buffers was at least 40% lower than with phosphate FASTA program of the GCG software package. The stron- 
40 gest homology was with the oxygenase component of vanil- buffers at the same pH. late demethylase (from Pseudomonas sp., ATCC strain 
The reaction scheme for the reaction catalyzed by the 191 5 1) which showed 33.8% identity, 
three components of dicamba 0-demethylase is presented in 
FIG. 1. Electrons from NADH are shuttled through a short Example 3 
electron chain consisting of the reductase and ferredoxin to 45 
the terminal oxygenase which catalyzes the oxidation of Purification and Characterization of Components of 
dicamba. The similarities between dicamba 0-demethylase Dicamba 0-Demethylase of Pseudomonas 
and several multicomponent dioxygenases suggest that maltophilia DI-6 
dicamba 0-demethylase may potentially possess cryptic 
diOx~genase activity. It is however, that this enzyme is 50 Bacterial cultures and preparation of cleared cell lysates. 
in the diOx~genases which OZ and incOr- Pseudomonas maltophilia, strain DI-6, was inoculated into 
porate one atom of oxygen into the major substrate and the 
,iX two-liter ~~l~~~~~~ flasks containing one liter of 
other into a small organic substrate such as a-ketoglutarate reduced chloride medium ( K ~ ~ ~ ~ ~ ~ ,  J, P, 1989, p h , ,  thesis, 
(FukumOri and Hausinger J. Biol. Chem. Illinois Institute of Technology, Chicago) supplemented 
268:24311p24317). Indeed, combinations of highly purified 55 with glucose (2.0 rngIml) and Casmino acids (2.0 rngIml) 
reductase~rc, ferredoxin~rc, and ox~genased~rc  require as the carbon sources. Cultures were incubated on an orbital 
only O,, NADH, M~", ~e" ,  and dicamba for activity. shaker (225 rpm at 30' C.). Cells were harvested at an A,,, 
ranging from 1.5 to 2.0 using a JLA-10.500 rotor in a 
Example 2 Beckman Avanti J-251 Centrifuge at 4 , 0 0 0 ~  g for 20 min- 
60 utes. Pelleted cells were stored at -80' C. The frozen cells 
Identification and Sequencing of a Clone Coding were resuspended in 40 ml of 100 mM MgCl,, pelleted 
for the Oxygenase of Dicamba 0-Demethylase of again using the same conditions as above, and then resus- 
Pseudomonas maltophilia DI-6 pended in breaking buffer (100 mM 3-[N-morpholino]pro- 
panesulfonic acid (MOPS) (pH 7.2), 1 mM dithiothreitol, 
As noted in Example 1, the first 29 amino acids of the 65 5% glycerol) in a ratio of 2 ml breaking buffer per gram of 
N-terminal amino acid sequence of oxygenase,,, had been cells wet weight. Lysozyme was added in a ratio of 80 pl per 
determined to be (residues in parentheses are best guesses): gram of cells along with a Protease Inhibitor Cocktail for 
US 7,105,724 B2 
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bacterial extracts (Sigma, P 8465) in a ratio of 5 ml per 20 Pharmacia Mono Q HR 515 column that was equilibrated in 
grams of cells wet weight. Finally, phenylmethylsulfonyl buffer C. The column was developed with a linear gradient 
fluoride (0.1 M stock solution in 100% ethanol) was added of 0-2.0 M NaCl in buffer C at a flow rate of 0.5 mllmin. 
in a ratio of 250 pl per 50 ml of breaking buffer. The cells Fractions that showed reductase activity were assayed for 
were disrupted with a sonicator (Sonics and Materials Inc., 5 protein content and stored at -80' C. 
Model VCX 600) in 9.0 second bursts, with 3.0 second Rapid enzyme assays. Activity for each of the three 
resting periods, for 30 minutes at an amplitude of 50%. individual components was monitored in reactions using 
Lysed cells were centrifuged for 75 minutes at 56 ,000~ g in 14c-labeled dicamba in a reaction containing an excess of 
a JA-25.50 rotor of a Beckman Avanti J-251 Centrifuge at 4' the remaining two components. For each reaction, a buffer 
C. The supernatant (cleared cell lysate) was decanted and l o  solution composed of 24 mM potassium phosphate (KP,) 
glycerol was added to a final concentration of 15% prior to buffer (pH 7.0), 0.48 mM NADH, 0.48 mM FeSO, and 9.6 
storage at -80' C. mM MgCl, was added to 200 p1 of protein sample along 
Initial purification of dicamba 0-demethylase compo- with 30 pl of master mix (562.4 p1 sterile water, 12.0 p1 50 
nents. An aliquot of the cleared cell lysate containing mM dicamba and 25.6 p1 14C-dicamba stock solution [1.28 
approximately 2.7 grams of protein was applied to a Phar- 1s pCi]) for a total volume of 31 1 p1 and a 14c-dicamba specific 
macia XK 26160 column containing 25 ml of DEAE- activity of 4.12 pCLC,iml. After 60 min, each reaction was 
Sepharose Fast Flow equilibrated with 50 mM MOPS stopped by the addition of 50 ~ 1 5 %  H,SO, (vlv) and 500 p1 
(pH7.2), 1 mM dithiothreitol, and 15% (vlv) glycerol (buffer ether. Reaction tubes were vortexed and centrifuged in a 
A). The column was connected to a Bio-CAD Perfusion microfuge (Eppendorf, Model 5415C) at 14 ,000~ g for 2 
Chromatography Workstation (USDA NRICGP Grant 20 minutes. For a quick visual appraisal of enzymatic activity, 
#9504266) and run at a flow rate of 5.0 mllmin. After the each reaction tube was placed under a hand-held W light 
column was loaded, it was washed with buffer A until the (Fotodyne Inc., Model 3-6000) to detect fluorescence of the 
absorbance reading at 280 nm decreased to below 0.1. All reaction product, DCSA. For more accurate, semi-quantita- 
three components of dicamba 0-demethylase were bound to tive measurements of enzymatic activities, reaction products 
the DEAE column under these conditions. The column was 25 were separated using thin layer chromatography as 
developed with a linear gradient of 0 to 500 mM NaCl in described in Example 1. 
buffer A. This resulted in the elution of the ferredoxin at 400 Protein concentration determinations. The fractions 
mM NaCl and the co-elution of the reductase and oxygenase obtained at different stages of the purification protocol were 
components at 250 mM NaCl. assayed for protein concentration using the Bradford assay 
Purification of the ferredoxinDrc. Fractions containing the 30 (standard protocol; Bio-Rad; see Example 1). 
ferredoxinDrc eluted from the DEAE-Sepharose column 
were pooled and buffer exchanged into 50 mM MOPS (pH Example 4 
7.2), 5% glycerol (vlv) and 200 mM NaCl (buffer B). They 
were then concentrated to approximately 2 ml using a Identification and Sequencing of a Clone Coding 
Amicon Cell Concentrator with a YMlO membrane and a 35 for FerredoxinDrc 
Centricon 10 concentrator. This sample was then applied to 
a pre-packed Pharmacia HiPrep 26160 Sephacryl S-100 The N-terminal sequence obtained from the purified ferre- 
column equilibrated with buffer B and run at a flow rate of doxin protein (purification described in Example 3) was 29 
0.5 mllmin on a Pharmacia FPLC apparatus. Fractions that amino acids in length (sequencing of proteins was per- 
showed activity were pooled and buffer exchanged into 50 40 formed by the Protein Core Facility at the University of 
mM MOPS (pH 7.2), 1 mM dithiothreitol and 5% glycerol Nebraska-Lincoln using a standard Edman degradation pro- 
(vlv) (buffer C). The fractions were concentrated to approxi- cedure; see Example 1). A comparison of this sequence to 
mately 2 ml and then loaded onto a Pharmacia Mono Q HR the Genbank database showed that it was 35% identical in a 
515 column equilibrated in buffer C. The column was 26 amino acid overlap to a terpredoxin from Pseudomonas 
developed with a linear gradient of 6 2 . 0  M NaCl in buffer 45 sp., a bacterial [2Fe-2S] ferredoxin in the adrenodoxin 
C. Fractions that contained ferredoxin activity were assayed family. The sequence information was used to design three 
for protein content and stored at -80' C. degenerate oligonucleotide primers (two forward and one 
Purification of the reductase,,,. Fractions from the initial reverse). The sequence of the two 17mer forward primers 
DEAE-Sepharose column containing the oxygenaselreduc- was based on the N-terminal amino acid sequence obtained 
tase components were pooled, and ammonium sulfate was 50 from the purified ferredoxin protein. The sequence of the 
added to a final concentration of 1.5 M. After incubating at 17mer reverse primer was based on a conserved sequence of 
4" C. for 1.5 hours, the samples were centrifuged for 75 six amino acids near the C-terminal end of six previously 
minutes at 56 ,000~ g at 4' C. in a JA-25.50 rotor of a sequenced bacterial adrenodoxin-type ferredoxins. The 
Beckman Avanti J-251 centrifuge. The supernatant was primers were used in a nested PCR reaction to amplify a 191 
retained and loaded at a flow rate of 5.0 mllmin onto a 55 bp product from total P maltophilia DNA. The product was 
Pharmacia XK 26120 column containing 25 ml of Phenyl- cloned into the pGEM-T Easy vector (Promega, Madison, 
Sepharose 6 Fast Flow (high sub) that was equilibrated in Wis.) and sequenced. DNA sequencing was performed by 
buffer A containing 1.5 M (NH,),SO,. Fractions that con- the DNA Sequencing Core Facility at the University of 
tained the reductase component were pooled, buffer Nebraska-Lincoln using a standard dideoxy-mediated chain 
exchanged into buffer B, and concentrated to approximately 60 termination procedure. An analysis of the predicted amino 
2 ml using the Amicon concentrator with an YM30 mem- acid sequence of this clone confirmed that it matched the 
brane and a Centriconlo concentrator. The 2 ml sample was N-terminal and internal amino acid sequence previously 
applied to a pre-packed Pharmacia HiPrep 26160 Sephacryl obtained from the purified ferredoxin protein. Furthermore, 
S-100 column equilibrated in buffer B and run at 0.5 mllmin. the derived amino acid sequence had 48% identity over its 
Fractions containing reductase activity were pooled, buffer 65 entire length with a [2Fe-2S] ferredoxin from Rhodobacter 
exchanged into buffer C, and concentrated down to approxi- capsulatus. The cloned fragment was labeled with digoxi- 
mately 2 ml. The 2 ml sample was loaded onto a pre-packed genin (DIG) (Roche Diagnostics) using a standard PCR 
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protocol (DIGIGenius System User's Guide) and hybridized cytochrome P-450 type reductase component of the dioxin 
by a Southern blot to total P maltophilia DNA that had been dioxygenase from Sphingomonas sp. RW1. 
digested with a number of restriction enzymes. A map of the The cloned fragment was labeled with DIG and hybrid- 
restriction sites surrounding the gene was constructed based ized by a Southern blot to total P maltophilia DNA that had 
on the sizes of the restriction fragments that hybridized to 5 been digested with a number of restriction enzymes. The 
the probe. This initial experiment showed that the gene was Southern blot showed that the DIG-labeled probe recognized 
contained on a Xho IIPst I fragment that was approximately two distinct loci in the various restriction digests of P 
1 kb in length. Subsequently, total P maltophilia DNA was maltophilia total DNA. This observation suggested that 
digested with Xho I and Pst I, and the restriction fragments there are two reductase genes located at different positions 
were resolved on a gel. Fragments between 0.5 and 1.5 kb 10 in the genome of P maltophilia. It was possible that the two 
in length were excised from the gel, ligated into the vector genes are identical duplications that encode identical reduc- 
pBluescript I1 KS+ (Stratagene, Inc.) and transformed into tase proteins. Alternatively, one of the genes could encode a 
DH5a cells (Gibco BRL, Inc.). Bacterial colonies contain- truncated protein with no activity or a full-length protein 
ing the size-fractionated library were screened with the with low activity in our dicamba 0-demethylase assay. 
DIG-labeled probe and a 900 bp Xho IIPst I fragment was 1s Because it was necessary to clone the gene that encodes a 
identified. Sequence analysis showed that this clone con- protein with optimal activity, the DIG-labeled probe was 
tained a full-length 3 18 bp ferredoxin gene [SEQ ID NO:4] used to retrieve both reductase genes. 
that encoded an 11.4 kDa protein composed of 105 amino When total P maltophilia DNA was digested with Kpn I 
acid residues [SEQ ID NO:5]. The amino acid sequence and EcoR I, the DIG-labeled probe hybridized to one 
predicted by the cloned gene matched the N-terminal and 20 restriction fragment that was approximately 4.0 kb in length 
internal amino acid sequence previously obtained from the and to another larger fragment with a size of approximately 
purified ferredoxin protein. Furthermore, the predicted 20 kb. Amap of a number of restriction sites surrounding the 
amino acid sequence was homologous over its entire length gene located on the 4.0 kb Kpn IIEcoR I fragment was 
to five other members of the adrenodoxin family of [2Fe-2S] constructed based on the sizes of different restriction frag- 
bacterial ferredoxins, ranging from 42% identity with a 25 ments that hybridized to the probe. The restriction map 
ferredoxin from Rhodobacter capsulatus to 35% identity indicated that the entire gene should be located on this 4.0 
with a ferredoxin from Pseudomonas (see FIG. 2). The other kb fragment. Subsequently, total P maltophilia DNA was 
three ferredoxins were from Caulobacter crescentus, Rhodo- digested with Kpn I and EcoR I, and the restriction frag- 
coccus erythropolis, and Pseudomonas putida. Proteins in ments were resolved on a gel. Fragments between 3.0 and 
this family bind a single 2Fe-2s iron-sulfur cluster and have 30 5.0 kb in length were excised from the gel, ligated into the 
three conserved motifs. Motif 1 includes three conserved vector pBluescript I1 KS+, and transformed into DH5a cells. 
cysteines which are 2Fe-2s ligands. Motif 2 contains a Bacterial colonies containing the size-fractionated library 
cluster of negatively charged residues. Motif 3 includes the were screened with the DIG-labeled probe and a 4.3 kb Kpn 
fourth conserved cysteine of the 2Fe-2s cluster. IIEcoR I fragment was identified. Sequence analysis showed 
35 that this clone contained a full-length 1224 bp reductase 
Example 5 gene [SEQ ID NO:6] and encoded a 43.7 kDa protein 
consisting of 408 amino acids [SEQ ID NO:7]. The amino 
Identification and Sequencing Of Clones Coding acid sequence predicted by the cloned gene matched the 
Reductase,,, N-terminal and internal amino acid sequence previously 
40 obtained from the vurified reductase vrotein. Furthermore. 
Two reductase genes were cloned by the same approach 
that was used in Example 4 to clone the ferredoxin gene. The 
N-terminal sequence obtained from the purified reductase 
protein (purification described in Example 3) was 25 amino 
acids in length. A comparison of this sequence to the 45 
Genbank database showed that it was 90% identical in a 20 
amino acid overlap to a cytochrome P450-type reductase 
component of dioxin dioxygenase, a three component 
enzyme previously isolated from Sphingomonas sp. RW1. 
An internal seauence of 10 amino acid residues was also 50 
the predicted amino acid sequence was homologous over its 
entire length to at least four other FAD-dependent pyridine 
nucleotide reductases, ranging from 69% identity with a 
cytochrome P450-type reductase component of dioxin 
dioxygenase from Sphingomonas sp. RW1 to 36% identity 
with the terpredoxin reductase from a Pseudomonas species 
(see FIG. 3). The two other FAD-dependent pyridine nucle- 
otide reductases were from R. erythropolis and P putida. 
Proteins in this family of FAD-dependent pyridine nucle- 
otide reductases have five conserved motifs. Motifs 1 and 3 
obtained from tryptic digests of the purified protein. The contain three conserved glycine residues and correspond to 
internal sequence had 87.5% identity with residues 62 the ADP binding site for FAD and NAD(P) respectively. 
through 69 of the same cytochrome P450-type reductase Motif 5 corresponds to the site binding the FAD flavin 
from Sphingomonas sp. RW1. This sequence information moiety. 
was used to design three degenerate oligonucleotide primers 55 To clone the second gene, total P maltophilia DNA was 
(two forward and one reverse). The sequence of the two digested with Kpn I and EcoR I and the resulting restriction 
17mer forward primers was based on the N-terminal amino fragments were resolved on an agarose gel. Fragments with 
acid sequence and the sequence of the 17mer reverse primer a size of approximately 20 kb were excised from the gel, 
was based on the internal amino acid sequence. The primers digested with a number of restriction enzymes, and then 
were used in a nested PCR reaction to amplify a 180 bp 60 hybridized by Southern blot to the DIG-labeled probe. A 
product from total P maltophilia DNA. The product was map of the restriction sites surrounding the second gene was 
cloned into the pGEM-T Easy vector and sequenced. An constructed based on the sizes of the restriction fragments 
analysis of the predicted amino acid sequence of this clone that hybridized to the probe. These experiments showed that 
confirmed that it encoded a protein that matched the N-ter- the full-length second reductase gene was contained on an 
minal and internal amino acid sequence obtained from the 65 Apa I fragment that was approximately 3.0 kb in length. 
purified reductase protein. Furthermore, the predicted Subsequently, total P maltophilia DNA was digested with 
sequence had 80% identity over its entire length with the Apa I and the restriction fragments were resolved on a gel. 
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Fragments between 2.0 and 4.0 kb in length were excised carrying the helper plasmid pRK2013 (for plasmid mobili- 
from the gel, ligated into the vector pBluescript I1 KS+, and zation). A. tumefaciens cells containing each of the con- 
transformed into DH5a cells. Bacterial colonies containing structs were then used to transform tobacco andArabidopsis 
the size-fractionated library were screened with the DIG- with the assistance of the plant Transformation Core 
hbeled probe and a 3.0 kb A P ~  I fragment was identified. 5  Research Facility. For tobacco, leaf explants were incubated 
Sequence analysis showed that the 3.0 kb clone contained an with a suspension  of^, tumefaciens cells containing each of 
'pen reading frame of 1227 bp rSEQ ID and encoded the constructs, and shoots were regenerated on solid medium 
a 43.9 kDa protein consisting of 409 amino acids [SEQ ID containing kanamycin ( ~ ~ ~ ~ ~ h  et al,, science, 
The amino acid sequence encoded by the second 227:1229-1231 (1985)). Ten shoots were selected from each 
reductase gene is almost identical (98.8% identity) to the l o  of the three transformation experiments, placed on rooting 
sequence of the first gene. medium for a few weeks, and then moved to pots in the 
greenhouse. For Arabidopsis, a pot of plants with flowers 
Example 6 was incubated with a suspension of A. tumefaciens cells 
containing each of the constructs, and the plants were then 
Transformation of Plants l 5  allowed to set seed (Bechtold et al., C. R. Acad. Sci. Paris, 
In order to place each of the three genes that encode the 
components of dicamba O-demethylase individually into 
cassettes suitable for expression in plants, the following 
steps were taken. Oligonucleotide primers were designed to 
generate a Nco I site at the 5' end and an Xba I site at the 3' 
end of each of the three genes by PCR amplification. The 
authenticity of the resulting PCR products was confirmed by 
sequencing, and each gene was then cloned individually into 
the pRTL2 vector (provided by Dr. Tom Clemente of the 
Plant Transformation Core Research Facility, University of 
Nebraska, Lincoln, Nebr.). This vector contains a 144 bp 
translation enhancer sequence from tobacco etch virus 
(TEV) (Carrington and Freed, J. Virology, 64: 1590-1 597 
(1990)) at the 5' end of the polylinker. The oxygenase, 
reductase, and ferredoxin genes, each with a 5' translation 
enhancer, were then cloned individually as Xho IRba I 
fragments into the plant expression vector pKLP36 (ob- 
tained from Indu Maiti, University of Kentucky, Lexington, 
Ky.) (Maiti and Shepard, Biochem. Biophys. Res. Commun., 
244:440444 (1998)). This binary vector contains the peanut 
chlorotic virus full-length promoter (PCISV FLt36) with a 
duplicated enhancer domain for constitutive expression in 
plants and the pea rbcS 3' sequence for efficient transcript 
termination (Maiti and Shepherd, Biochem. Biophys. Res. 
Commun., 244:440-444 (1998)). Constructs with all three 
genes on one binary vector can be produced using combi- 
nations of the three genes in a number of different orders and 
orientations. 
The following methods were employed to move the 
oxygenase, ferredoxin, and reductase constructs individually 
into Agrobacterium tumefaciens and to transform each con- 
struct into Arabidopsis and tobacco. The three constructs 
were moved into the A. tumefaciens strain C58C1 by a 
modified triparental mating procedure routinely used by the 
Plant Transformation Core Research Facility. This involved 
incubating Escherichia coli cells carrying each construct 
with a mixture of A. tumefaciens cells and E. coli cells 
Sciences de la vie/~ife sciences, 3 16: 11 94-1 199 (1 993); 
Clough and Bent, Plant J., 16 (6):735-743 (1998)). The seed 
was collected and germinated on medium with kanamycin. 
After the seedlings had developed an adequate root system, 
several plants were selected from each transformation 
experiment and moved to pots in a growth chamber. 
For evaluation of the expression of each gene in the 
transformed plants, Western blots of leaf lysates from sev- 
eral transformed plants were prepared and probed with 
polyclonal antibodies that detect the three components of 
dicamba O-demethylase. To determine enzyme activities for 
each enzyme in plant extracts, the approach was to combine 
leaf lysates from transformed plants expressing the oxyge- 
nase, ferredoxin or reductase proteins with excess amounts 
of the other O-demethylase components purified from P 
maltophilia strain DI-6. These mixtures were tested for 
dicamba O-demethylase activity with both the standard 
14 C-labeled dicamba assay (see Examples 1 and 3) and an 
HPLC assay employing nonradioactive dicamba as substrate 
(dicamba and 3,6-DCSA elute at different points from the 
HPLC and can be quantitated). 
To test expression of gene products in the chloroplast 
compartment, constructs were made with a transit peptide 
sequence at the 5' end of the oxygenase, ferredoxin, and 
reductase genes. Such an approach was successful for intro- 
ducing tolerance to the sulfonylurea herbicides into tobacco 
plants (O'Keefe et al., Plant Physiol., 105:473478 (1994)). 
To test the possibility that the codon usage of the bacterial 
ferredoxin gene was not fully optimal for efficient transla- 
tion in a plant cell, a synthetic ferredoxin gene encoding the 
same amino acid sequence as the P maltophilia strain DI-6 
ferredoxin, but with optimized codon bias for dicot plants 
was synthesized by Entelechon, GmbH (Regensberg, Ger- 
many). It has been well documented that changes in codon 
usage are essential for optimal expression of the bacterial 
B.t. toxin genes in plant cells (see, e.g., Diehn et al., Genetic 
Engineering, 18: 83-99 (1 996)). 
SEQUENCE L I S T I N G  
< 1 6 0 >  NUMBER O F  S E Q  I D  NOS: 1 8  
< 2 1 0 >  S E Q  I D  NO 1 
< 2 1 1 >  LENGTH: 2 9  
< 2 1 2 >  TYPE:  P R T  
< 2 1 3 >  ORGANISM: P s e u d o m o n a s  m a l t o p h i l i a  D I - 6  
<2 2 0 > FEATURE : 
< 2 2 1 >  NAME/KEY: u n s u r e  
< 2 2 2 >  LOCATION: ( 2 8 ) . . ( 2 8 )  
<223>  OTHER INFORMATION: B e s t  g u e s s  f o r  X a a  = A s p  o r  T h r  
<221>  NAME/KEY: u n s u r e  
<222>  LOCATION: ( 2 9 ) . . ( 2 9 )  
<223>  OTHER INFORMATION: B e s t  g u e s s  f o r  X a a  = P r o  
<400>  SEQUENCE: 1 
T h r  P h e  V a l  A r g  A s n  A l a  T r p  T y r  V a l  A l a  A l a  L e u  P r o  G l u  G l u  L e u  
1 5 1 0  1 5  
S e r  G l u  L y s  P r o  L e u  G l y  A r g  T h r  I l e  L e u  A s p  X a a  X a a  
2 0  2  5  
<210>  SEQ I D  NO 2  
<211>  LENGTH: 1 0 2 0  
<212>  TYPE: DNA 
<213>  ORGANISM: P s e u d o m o n a s  m a l t o p h i l i a  DI -6  
<220>  FEATURE: 
<221>  NAME/KEY: CDS 
<222>  LOCATION: ( 1 ) . . ( 1 0 2 0 )  
<400>  SEQUENCE: 2  
a t g  acc t t c  g t c  c g c  a a t  g c c  t g g  t a t  g t g  g c g  g c g  c t g  ccc g a g  g a a  
M e t  T h r  P h e  V a l  A r g  A s n  A l a  T r p  T y r  V a l  A l a  A l a  L e u  P r o  G l u  G l u  
1 5 1 0  1 5  
c t g  t c c  g a a  a a g  c c g  c t c  g g c  c g g  a c g  a t t  c t c  g a c  aca c c g  c t c  g c g  
L e u  S e r  G l u  L y s  P r o  L e u  G l y  A r g  T h r  I l e  L e u  A s p  T h r  P r o  L e u  A l a  
2 0  2  5  3 0  
c t c  t a c  c g c  c a g  ccc g a c  g g t  g t g  g t c  g c g  g c g  c t g  c t c  g a c  a t c  t g t  
L e u  T y r  A r g  G l n  P r o  A s p  G l y  V a l  V a l  A l a  A l a  L e u  L e u  A s p  I l e  C y s  
3  5  40 4  5  
c c g  cac c g c  t t c  g c g  c c g  c t g  a g c  g a c  g g c  a t c  c t c  g t c  aac g g c  c a t  
P r o  H i s  A r g  P h e  A l a  P r o  L e u  S e r  A s p  G l y  I l e  L e u  V a l  A s n  G l y  H i s  
5 0  5 5  6  0  
c t c  caa t g c  ccc t a t  cac g g g  c t g  g a a  t t c  g a t  g g c  g g c  g g g  c a g  t g c  
L e u  G l n  C y s  P r o  T y r  H i s  G l y  L e u  G l u  P h e  A s p  G l y  G l y  G l y  G l n  C y s  
6 5  7  0  7 5  8 0  
g t c  c a t  aac c c g  cac g g c  a a t  g g c  g c c  c g c  c c g  g c t  t c g  c t c  aac g t c  
V a l  H i s  A s n  P r o  H i s  G l y  A s n  G l y  A l a  A r g  P r o  A l a  S e r  L e u  A s n  V a l  
8 5  9 0  9  5  
c g c  t c c  t t c  c c g  g t g  g t g  g a g  c g c  g a c  g c g  c t g  a t c  t g g  a t c  t g g  ccc 
A r g  S e r  P h e  P r o  V a l  V a l  G l u  A r g  A s p  A l a  L e u  I l e  T r p  I l e  T r p  P r o  
1 0 0  1 0 5  1 1 0  
g g c  g a t  c c g  g c g  c t g  g c c  g a t  c c t  g g g  g c g  a t c  ccc g a c  t t c  g g c  t g c  
G l y  A s p  P r o  A l a  L e u  A l a  A s p  P r o  G l y  A l a  I l e  P r o  A s p  P h e  G l y  C y s  
1 1 5  1 2 0  1 2 5  
c g c  g t c  g a t  ccc g c c  t a t  c g g  acc g t c  g g c  g g c  t a t  g g g  c a t  g t c  g a c  
A r g  V a l  A s p  P r o  A l a  T y r  A r g  T h r  V a l  G l y  G l y  T y r  G l y  H i s  V a l  A s p  
1 3 0  1 3 5  1 4 0  
t g c  aac t a c  a a g  c t g  c t g  g t c  g a c  aac c t g  a t g  g a c  c t c  g g c  cac g c c  4 8 0  
C y s  A s n  T y r  L y s  L e u  L e u  V a l  A s p  A s n  L e u  M e t  A s p  L e u  G l y  H i s  A l a  
1 4 5  1 5 0  1 5 5  1 6 0  
caa t a t  g t c  c a t  c g c  g c c  aac g c c  c a g  acc g a c  g c c  t t c  g a c  c g g  c t g  5 2 8  
G l n  T y r  V a l  H i s  A r g  A l a  A s n  A l a  G l n  T h r  A s p  A l a  P h e  A s p  A r g  L e u  
1 6 5  1 7 0  1 7 5  
g a g  c g c  g a g  g t g  a t c  g t c  g g c  g a c  g g t  g a g  a t a  c a g  g c g  c t g  a t g  a a g  5 7 6  
G l u  A r g  G l u  V a l  I l e  V a l  G l y  A s p  G l y  G l u  I l e  G l n  A l a  L e u  M e t  L y s  
1 8 0  1 8 5  1 9 0  
a t t  ccc g g c  g g c  a c g  c c g  a g c  g t g  c t g  a t g  g c c  a a g  t t c  c t g  c g c  g g c  6 2 4  
I l e  P r o  G l y  G l y  T h r  P r o  S e r  V a l  L e u  M e t  A l a  L y s  P h e  L e u  A r g  G l y  
1 9 5  2 0 0  2 0 5  
g c c  a a t  acc ccc g t c  g a c  g c t  t g g  aac g a c  a t c  c g c  t g g  aac a a g  g t g  6 7 2  
A l a  A s n  T h r  P r o  V a l  A s p  A l a  T r p  A s n  A s p  I l e  A r g  T r p  A s n  L y s  V a l  
2 1 0  2  1 5  2 2 0  
a g c  g c g  a t g  c t c  aac t t c  a t c  g c g  g t g  g c g  c c g  g a a  g g c  acc c c g  a a g  
S e r  A l a  M e t  L e u  A s n  P h e  I l e  A l a  V a l  A l a  P r o  G l u  G l y  T h r  P r o  L y s  
2 2 5  2 3 0  2 3 5  2 4 0  
g a g  c a g  a g c  a t c  cac t c g  c g c  g g t  acc c a t  a t c  c t g  acc ccc g a g  a c g  
G l u  G l n  S e r  I l e  H i s  S e r  A r g  G l y  T h r  H i s  I l e  L e u  T h r  P r o  G l u  T h r  
2 4 5  2 5 0  2 5 5  
g a g  g c g  a g c  t g c  c a t  t a t  t t c  t t c  g g c  t c c  t c g  c g c  a a t  t t c  g g c  a t c  
G l u  A l a  S e r  C y s  H i s  T y r  P h e  P h e  G l y  S e r  S e r  A r g  A s n  P h e  G l y  I l e  
2 6 0  2 6 5  2 7 0  
g a c  g a t  c c g  g a g  a t g  g a c  g g c  g t g  c t g  c g c  a g c  t g g  c a g  g c t  c a g  g c g  
A s p  A s p  P r o  G l u  M e t  A s p  G l y  V a l  L e u  A r g  S e r  T r p  G l n  A l a  G l n  A l a  
2 7 5  2 8 0  2 8 5  
c t g  g t c  a a g  g a g  g a c  a a g  g t c  g t c  g t c  g a g  g c g  a t c  g a g  c g c  c g c  c g c  
L e u  V a l  L y s  G l u  A s p  L y s  V a l  V a l  V a l  G l u  A l a  I l e  G l u  A r g  A r g  A r g  
2 9 0  2 9 5  3 0 0  
g c c  t a t  g t c  g a g  g c g  a a t  g g c  a t c  c g c  c c g  g c g  a t g  c t g  t c g  t g c  g a c  
A l a  T y r  V a l  G l u  A l a  A s n  G l y  I l e  A r g  P r o  A l a  M e t  L e u  S e r  C y s  A s p  
3 0 5  3 1 0  3  1 5  3 2 0  
g a a  g c c  g c a  g t c  c g t  g t c  a g c  c g c  g a g  a t c  g a g  a a g  c t t  g a g  c a g  c t c  
G l u  A l a  A l a  V a l  A r g  V a l  S e r  A r g  G l u  I l e  G l u  L y s  L e u  G l u  G l n  L e u  
3 2 5  3 3 0  3 3 5  
g a a  g c c  g c c  t g a  
G l u  A l a  A l a  
<210>  SEQ I D  NO 3  
<211>  LENGTH: 3 3 9  
<212>  TYPE: PRT 
<213>  ORGANISM: P s e u d o m o n a s  m a l t o p h i l i a  DI -6  
<400>  SEQUENCE: 3  
M e t  T h r  P h e  V a l  A r g  A s n  A l a  T r p  T y r  V a l  A l a  A l a  L e u  P r o  G l u  G l u  
1 5  1 0  1 5  
L e u  S e r  G l u  L y s  P r o  L e u  G l y  A r g  T h r  I l e  L e u  A s p  T h r  P r o  L e u  A l a  
2 0  2  5  3 0  
L e u  T y r  A r g  G l n  P r o  A s p  G l y  V a l  V a l  A l a  A l a  L e u  L e u  A s p  I l e  C y s  
3  5  40 4  5  
P r o  H i s  A r g  P h e  A l a  P r o  L e u  S e r  A s p  G l y  I l e  L e u  V a l  A s n  G l y  H i s  
5 0  5 5  6  0  
L e u  G l n  C y s  P r o  T y r  H i s  G l y  L e u  G l u  P h e  A s p  G l y  G l y  G l y  G l n  C y s  
6 5  7  0  7 5  8 0  
V a l  H i s  A s n  P r o  H i s  G l y  A s n  G l y  A l a  A r g  P r o  A l a  S e r  L e u  A s n  V a l  
8 5  9 0  9  5  
A r g  S e r  P h e  P r o  V a l  V a l  G l u  A r g  A s p  A l a  L e u  I l e  T r p  I l e  T r p  P r o  
1 0 0  1 0 5  1 1 0  
G l y  A s p  P r o  A l a  L e u  A l a  A s p  P r o  G l y  A l a  I l e  P r o  A s p  P h e  G l y  C y s  
1 1 5  1 2 0  1 2 5  
A r g  V a l  A s p  P r o  A l a  T y r  A r g  T h r  
1 3 0  1 3 5  
V a l  G l y  G l y  T y r  G l y  H i s  V a l  
1 4 0  
C y s  A s n  T y r  L y s  L e u  L e u  V a l  A s p  A s n  L e u  M e t  A s p  L e u  G l y  H i s  A l a  
1 4 5  1 5 0  1 5 5  1 6 0  
G l n  T y r  V a l  H i s  A r g  A l a  A s n  A l a  G l n  T h r  A s p  A l a  P h e  A s p  A r g  L e u  
1 6 5  1 7 0  1 7 5  
G l u  A r g  G l u  V a l  I l e  V a l  G l y  A s p  G l y  G l u  I l e  G l n  A l a  L e u  M e t  L y s  
1 8 0  1 8 5  1 9 0  
I l e  P r o  G l y  G l y  T h r  P r o  S e r  V a l  L e u  M e t  A l a  L y s  P h e  L e u  A r g  G l y  
1 9 5  2 0 0  2 0 5  
A l a  A s n  T h r  P r o  V a l  A s p  A l a  T r p  A s n  A s p  I l e  A r g  T r p  A s n  L y s  V a l  
2 1 0  2  1 5  2 2 0  
S e r  A l a  M e t  L e u  A s n  P h e  I l e  A l a  V a l  A l a  P r o  G l u  G l y  T h r  P r o  L y s  
2 2 5  2 3 0  2 3 5  2 4 0  
G l u  G l n  S e r  I l e  H i s  S e r  A r g  G l y  T h r  H i s  I l e  L e u  T h r  P r o  G l u  T h r  
2 4 5  2 5 0  2 5 5  
G l u  A l a  S e r  C y s  H i s  T y r  P h e  P h e  G l y  S e r  S e r  A r g  A s n  P h e  G l y  I l e  
2 6 0  2 6 5  2 7 0  
A s p  A s p  P r o  G l u  M e t  A s p  G l y  V a l  L e u  A r g  S e r  T r p  G l n  A l a  G l n  A l a  
2 7 5  2 8 0  2 8 5  
L e u  V a l  L y s  G l u  A s p  L y s  V a l  V a l  V a l  G l u  A l a  I l e  G l u  A r g  A r g  A r g  
2 9 0  2 9 5  3 0 0  
A l a  T y r  V a l  G l u  A l a  A s n  G l y  I l e  A r g  P r o  A l a  M e t  L e u  S e r  C y s  A s p  
3 0 5  3 1 0  3  1 5  3 2 0  
G l u  A l a  A l a  V a l  A r g  V a l  S e r  A r g  G l u  I l e  G l u  L y s  L e u  G l u  G l n  L e u  
3 2 5  3 3 0  3 3 5  
G l u  A l a  A l a  
<210>  SEQ I D  NO 4  
<211>  LENGTH: 3 1 8  
<212>  TYPE: DNA 
<213>  ORGANISM: P s e u d o m o n a s  m a l t o p h i l i a  DI -6  
<220>  FEATURE: 
<221>  NAME/KEY: CDS 
<222>  LOCATION: ( 1 ) . . ( 3 1 8 )  
<400>  SEQUENCE: 4  
a t g  c c g  c a g  a t t  acc g t c  g t c  aac c a g  t c g  g g t  g a a  g a a  t c c  a g c  g t c  
M e t  P r o  G l n  I l e  T h r  V a l  V a l  A s n  G l n  S e r  G l y  G l u  G l u  S e r  S e r  V a l  
1 5 1 0  1 5  
g a g  g c g  a g t  g a a  g g c  c g c  acc c t g  a t g  g a a  g t c  a t c  c g c  g a c  a g c  g g t  
G l u  A l a  S e r  G l u  G l y  A r g  T h r  L e u  M e t  G l u  V a l  I l e  A r g  A s p  S e r  G l y  
2 0  2  5  3 0  
ttt g a c  g a a  c t c  c t g  g c g  c t t  t g c  g g c  g g c  t g c  t g c  t c g  t g c  g c g  acc 
P h e  A s p  G l u  L e u  L e u  A l a  L e u  C y s  G l y  G l y  C y s  C y s  S e r  C y s  A l a  T h r  
3  5  40 4  5  
t g c  cac g t c  cac a t c  g a c  c c g  g c c  t t c  a t g  g a c  a a g  c t g  c c g  g a g  a t g  
C y s  H i s  V a l  H i s  I l e  A s p  P r o  A l a  P h e  M e t  A s p  L y s  L e u  P r o  G l u  M e t  
5 0  5 5  6 0  
a g c  g a a  g a c  g a g  aac g a c  c t g  c t c  g a c  a g c  t c g  g a c  cac c g c  aac g a g  
S e r  G l u  A s p  G l u  A s n  A s p  L e u  L e u  A s p  S e r  S e r  A s p  H i s  A r g  A s n  G l u  
6 5  7  0  7 5  8 0  
t a c  t c g  c g t  c t c  t c g  t g c  c a g  a t t  c c g  g t c  acc g g c  g c c  c t c  g a a  g g c  
T y r  S e r  A r g  L e u  S e r  C y s  G l n  I l e  P r o  V a l  T h r  G l y  A l a  L e u  G l u  G l y  
8 5  9 0  9  5  
a t c  a a g  g t g  a c g  a t c  g c g  c a g  g a a  g a c  t g a  
I l e  L y s  V a l  T h r  I l e  A l a  G l n  G l u  A s p  
1 0 0  1 0 5  
<210>  SEQ I D  NO 5  
<211>  LENGTH: 1 0 5  
<212>  TYPE: PRT 
<213>  ORGANISM: P s e u d o m o n a s  m a l t o p h i l i a  DI -6  
<400>  SEQUENCE: 5  
M e t  P r o  G l n  I l e  T h r  V a l  V a l  A s n  G l n  S e r  G l y  G l u  G l u  S e r  S e r  V a l  
1 5 1 0  1 5  
G l u  A l a  S e r  G l u  G l y  A r g  T h r  L e u  M e t  G l u  V a l  I l e  A r g  A s p  S e r  G l y  
2 0  2  5  3 0  
Phe Asp Glu Leu Leu Ala Leu Cys Gly Gly Cys Cys S e r  Cys Ala Thr 
3  5  40 4  5  
Cys His  Val His  I l e  Asp Pro  Ala Phe Met Asp Lys Leu Pro  Glu Met 
5 0  5 5  6  0  
S e r  Glu Asp Glu Asn Asp Leu Leu Asp S e r  Ser  Asp His  Arg Asn Glu 
6 5  7  0  7 5  8 0  
Tyr S e r  Arg Leu S e r  Cys Gln I l e  Pro  Val Thr Gly Ala Leu Glu Gly 
8 5  9 0  9  5  
I l e  Lys Val Thr I l e  Ala Gln Glu Asp 
1 0 0  1 0 5  
<210>  SEQ I D  NO 6  
<211>  LENGTH: 1 2 2 7  
<212>  TYPE: DNA 
<213>  ORGANISM: Pseudomonas m a l t o p h i l i a  DI-6 
<220>  FEATURE: 
<221>  NAME/KEY: CDS 
<222>  LOCATION: ( 1 ) . . ( 1 2 2 7 )  
<400>  SEQUENCE: 6  
a t g  agc aag gca gac g t c  g t a  a t c  g t g  gga gcc ggg c a t  ggc ggc gca 
Met S e r  Lys Ala Asp Val Val I l e  Val Gly Ala Gly His  Gly Gly Ala 
1 5 1 0  1 5  
cag t g c  gcg a t c  gcc c t t  cgc cag aac  ggc t t c  gaa gga acc  a t c  acc  
Gln Cys Ala I l e  Ala Leu Arg Gln Asn Gly Phe Glu Gly Thr I l e  Thr 
2 0  2  5  3 0  
g t c  a t c  g g t  c g t  gag ccg gaa t a t  ccc  t a t  gag c g t  ccg ccg c t c  t c g  
Val I l e  Gly Arg Glu Pro  Glu Tyr Pro  Tyr Glu Arg Pro  Pro  Leu S e r  
3  5  40 4  5  
aag gaa t a t  t t c  gcg cgc gag aag acc  t t c  gac cgc c t c  t a c  a t c  c g t  1 9 2  
Lys Glu Tyr Phe Ala Arg Glu Lys Thr Phe Asp Arg Leu Tyr I l e  Arg 
5 0  5 5  6  0  
ccg ccg acg t t c  t g g  gcc gag aag aac  a t c  gag t t c  aag c t t  ggc acc  2 4 0  
Pro  Pro  Thr Phe Trp Ala Glu Lys Asn I l e  Glu Phe Lys Leu Gly Thr 
6 5  7  0  7 5  8 0  
gaa g t c  acc  aag g t c  g a t  ccc  aag gcg cac  gaa c t g  acg c t c  t c c  aac  2 8 8  
Glu Val Thr Lys Val Asp Pro  Lys Ala His  Glu Leu Thr Leu S e r  Asn 
8 5  9 0  9  5  
ggc gag agc t a c  g g t  t a t  ggc aag c t c  g t c  t g g  gcc acc  ggc ggc g a t  3 3 6  
Gly Glu S e r  Tyr Gly Tyr Gly Lys Leu Val Trp Ala Thr Gly Gly Asp 
1 0 0  1 0 5  1 1 0  
ccg c g t  cgc c t t  t c t  t g c  cag ggg gcc gac c t c  acc  ggc a t c  cac  gcc 3 8 4  
Pro  Arg Arg Leu S e r  Cys Gln Gly Ala Asp Leu Thr Gly I l e  His  Ala 
1 1 5  1 2 0  1 2 5  
g t g  cgc acc  cgc gag gac t g c  gac acg c t g  a t g  gcc gaa g t c  g a t  gcg 4 3 2  
Val Arg Thr Arg Glu Asp Cys Asp Thr Leu Met Ala Glu Val Asp Ala 
1 3 0  1 3 5  1 4 0  
ggc acg aag aac  a t c  g t c  g t c  a t c  ggc ggc ggc t a c  a t c  g g t  c t g  gaa 4 8 0  
Gly Thr Lys Asn I l e  Val Val I l e  Gly Gly Gly Tyr I l e  Gly Leu Glu 
1 4 5  1 5 0  1 5 5  1 6 0  
gcc g c t  gcg g t g  c t g  t c c  aag a t g  ggc c t c  aag g t c  acc  c t g  c t c  gaa 5 2 8  
Ala Ala Ala Val Leu S e r  Lys Met Gly Leu Lys Val Thr Leu Leu Glu 
1 6 5  1 7 0  1 7 5  
gcg c t t  ccg cgc g t g  c t g  gcg cgc g t t  gcg g g t  gaa gac c t c  t c g  acc  5 7 6  
Ala Leu Pro  Arg Val Leu Ala Arg Val Ala Gly Glu Asp Leu S e r  Thr 
1 8 0  1 8 5  1 9 0  
t t c  t a c  cag aag gaa c a t  g t c  g a t  cac  ggc g t c  gac c t g  cgc acc  gaa 6 2 4  
Phe Tyr Gln Lys Glu His  Val Asp His  Gly Val Asp Leu Arg Thr Glu 
1 9 5  2 0 0  2 0 5  
g t c  a t g  g t c  gac agc c t c  g t c  ggc gaa aac  ggc aag g t c  acc  ggc g t g  6 7 2  
V a l  M e t  V a l  A s p  S e r  L e u  V a l  G l y  G l u  A s n  G l y  L y s  V a l  T h r  G l y  V a l  
2 1 0  2  1 5  2 2 0  
c a g  c t t  g c c  g g c  g g c  g a a  g t g  a t c  c c g  g c c  g a a  g g c  g t c  a t c  g t c  g g c  
G l n  L e u  A l a  G l y  G l y  G l u  V a l  I l e  P r o  A l a  G l u  G l y  V a l  I l e  V a l  G l y  
2 2 5  2 3 0  2 3 5  2 4 0  
a t c  g g c  a t c  g t g  c c t  g c c  g t c  g g t  c c g  c t g  a t c  g c g  g c c  g g c  g c g  g c c  
I l e  G l y  I l e  V a l  P r o  A l a  V a l  G l y  P r o  L e u  I l e  A l a  A l a  G l y  A l a  A l a  
2 4 5  2 5 0  2 5 5  
g g t  g c c  aac g g c  g t c  g a c  g t g  g a c  g a g  t a c  t g c  c g c  acc t c g  c t g  ccc 
G l y  A l a  A s n  G l y  V a l  A s p  V a l  A s p  G l u  T y r  C y s  A r g  T h r  S e r  L e u  P r o  
2 6 0  2 6 5  2 7 0  
g a c  a t c  t a t  g c g  a t c  g g c  g a c  t g t  g c g  g c t  t t c  g c c  t g c  g a c  t a c  g c c  
A s p  I l e  T y r  A l a  I l e  G l y  A s p  C y s  A l a  A l a  P h e  A l a  C y s  A s p  T y r  A l a  
2 7 5  2 8 0  2 8 5  
g g c  g g c  aac g t g  a t g  c g c  g t g  g a a  t c g  g t c  c a g  aac g c c  aac g a c  a t g  
G l y  G l y  A s n  V a l  M e t  A r g  V a l  G l u  S e r  V a l  G l n  A s n  A l a  A s n  A s p  M e t  
2 9 0  2 9 5  3 0 0  
g g c  acc t g c  g t g  g c c  a a g  g c g  a t c  t g c  g g c  g a c  g a g  a a g  ccc t a c  a a g  
G l y  T h r  C y s  V a l  A l a  L y s  A l a  I l e  C y s  G l y  A s p  G l u  L y s  P r o  T y r  L y s  
3 0 5  3 1 0  3  1 5  3 2 0  
g c g  t t c  c c g  t g g  t t c  t g g  t c c  aac c a g  t a c  g a c  c t c  a a g  c t g  c a g  acc 
A l a  P h e  P r o  T r p  P h e  T r p  S e r  A s n  G l n  T y r  A s p  L e u  L y s  L e u  G l n  T h r  
3 2 5  3 3 0  3 3 5  
g c c  g g c  a t c  aac c t g  g g c  t t c  g a c  a a g  acc g t g  a t c  c g c  g g c  a a t  c c g  
A l a  G l y  I l e  A s n  L e u  G l y  P h e  A s p  L y s  T h r  V a l  I l e  A r g  G l y  A s n  P r o  
3 4 0  3 4 5  3 5 0  
g a g  g a g  c g c  a g c  t t c  t c g  g t c  g t c  t a t  c t c  a a g  g a c  g g c  c g c  g t g  g t c  
G l u  G l u  A r g  S e r  P h e  S e r  V a l  V a l  T y r  L e u  L y s  A s p  G l y  A r g  V a l  V a l  
3 5 5  3 6 0  3 6 5  
g c g  c t g  g a c  t g c  g t g  aac a t g  g t c  a a g  g a t  t a c  g t g  c a g  g g c  c g c  a a g  
A l a  L e u  A s p  C y s  V a l  A s n  M e t  V a l  L y s  A s p  T y r  V a l  G l n  G l y  A r g  L y s  
3 7 0  3 7 5  3 8 0  
c t g  g t c  g a a  g c c  g g g  g c c  acc ccc g a c  c t c  g a a  g c g  c t g  g c c  g a t  g c c  
L e u  V a l  G l u  A l a  G l y  A l a  T h r  P r o  A s p  L e u  G l u  A l a  L e u  A l a  A s p  A l a  
3 8 5  3 9 0  3 9 5  400  
g g c  a a g  c c g  c t c  a a g  g a a  c t g  c t c  t a g  
G l y  L y s  P r o  L e u  L y s  G l u  L e u  L e u  
4 0 5  
<210>  SEQ I D  NO 7  
<211>  LENGTH: 408  
<212>  TYPE: PRT 
<213>  ORGANISM: P s e u d o m o n a s  m a l t o p h i l i a  DI -6  
<400>  SEQUENCE: 7 
M e t  S e r  L y s  A l a  A s p  V a l  V a l  I l e  V a l  G l y  A l a  G l y  H i s  G l y  G l y  A l a  
1 5  1 0  1 5  
G l n  C y s  A l a  I l e  A l a  L e u  A r g  G l n  A s n  G l y  P h e  G l u  G l y  T h r  I l e  T h r  
2 0  2  5  3 0  
V a l  I l e  G l y  A r g  G l u  P r o  G l u  T y r  P r o  T y r  G l u  A r g  P r o  P r o  L e u  S e r  
3  5  40 4  5  
L y s  G l u  T y r  P h e  A l a  A r g  G l u  L y s  T h r  P h e  A s p  A r g  L e u  T y r  I l e  A r g  
5 0  5 5  6  0  
P r o  P r o  T h r  P h e  T r p  A l a  G l u  L y s  A s n  I l e  G l u  P h e  L y s  L e u  G l y  T h r  
6 5  7  0  7 5  8 0  
G l u  V a l  T h r  L y s  V a l  A s p  P r o  L y s  A l a  H i s  G l u  L e u  T h r  L e u  S e r  A s n  
8 5  9 0  9  5  
G l y  G l u  S e r  T y r  G l y  T y r  G l y  L y s  L e u  V a l  T r p  A l a  T h r  G l y  G l y  A s p  
1 0 0  1 0 5  1 1 0  
P r o  A r g  A r g  L e u  S e r  C y s  G l n  G l y  A l a  A s p  L e u  T h r  G l y  I l e  H i s  A l a  
1 1 5  1 2 0  1 2 5  
V a l  A r g  T h r  A r g  G l u  A s p  C y s  A s p  T h r  L e u  M e t  A l a  G l u  V a l  A s p  A l a  
1 3 0  1 3 5  1 4 0  
G l y  T h r  L y s  A s n  I l e  V a l  V a l  I l e  G l y  G l y  G l y  T y r  I l e  G l y  L e u  G l u  
1 4 5  1 5 0  1 5 5  1 6 0  
A l a  A l a  A l a  V a l  L e u  S e r  L y s  M e t  G l y  L e u  L y s  V a l  T h r  L e u  L e u  G l u  
1 6 5  1 7 0  1 7 5  
A l a  L e u  P r o  A r g  V a l  L e u  A l a  A r g  V a l  A l a  G l y  G l u  A s p  L e u  S e r  T h r  
1 8 0  1 8 5  1 9 0  
P h e  T y r  G l n  L y s  G l u  H i s  V a l  A s p  H i s  G l y  V a l  A s p  L e u  A r g  T h r  G l u  
1 9 5  2 0 0  2 0 5  
V a l  M e t  V a l  A s p  S e r  L e u  V a l  G l y  G l u  A s n  G l y  L y s  V a l  T h r  G l y  V a l  
2 1 0  2  1 5  2 2 0  
G l n  L e u  A l a  G l y  G l y  G l u  V a l  I l e  P r o  A l a  G l u  G l y  V a l  I l e  V a l  G l y  
2 2 5  2 3 0  2 3 5  2 4 0  
I l e  G l y  I l e  V a l  P r o  A l a  V a l  G l y  P r o  L e u  I l e  A l a  A l a  G l y  A l a  A l a  
2 4 5  2 5 0  2 5 5  
G l y  A l a  A s n  G l y  V a l  A s p  V a l  A s p  G l u  T y r  C y s  A r g  T h r  S e r  L e u  P r o  
2 6 0  2 6 5  2 7 0  
A s p  I l e  T y r  A l a  I l e  G l y  A s p  C y s  A l a  A l a  P h e  A l a  C y s  A s p  T y r  A l a  
2 7 5  2 8 0  2 8 5  
G l y  G l y  A s n  V a l  M e t  A r g  V a l  G l u  S e r  V a l  G l n  A s n  A l a  A s n  A s p  M e t  
2 9 0  2 9 5  3 0 0  
G l y  T h r  C y s  V a l  A l a  L y s  A l a  I l e  C y s  G l y  A s p  G l u  L y s  P r o  T y r  L y s  
3 0 5  3 1 0  3  1 5  3 2 0  
A l a  P h e  P r o  T r p  P h e  T r p  S e r  A s n  G l n  T y r  A s p  L e u  L y s  L e u  G l n  T h r  
3 2 5  3 3 0  3 3 5  
A l a  G l y  I l e  A s n  L e u  G l y  P h e  A s p  L y s  T h r  V a l  I l e  A r g  G l y  A s n  P r o  
3 4 0  3 4 5  3 5 0  
G l u  G l u  A r g  S e r  P h e  S e r  V a l  V a l  T y r  L e u  L y s  A s p  G l y  A r g  V a l  V a l  
3 5 5  3 6 0  3 6 5  
A l a  L e u  A s p  C y s  V a l  A s n  M e t  V a l  L y s  A s p  T y r  V a l  G l n  G l y  A r g  L y s  
3 7 0  3 7 5  3 8 0  
L e u  V a l  G l u  A l a  G l y  A l a  T h r  P r o  A s p  L e u  G l u  A l a  L e u  A l a  A s p  A l a  
3 8 5  3 9 0  3 9 5  400  
G l y  L y s  P r o  L e u  L y s  G l u  L e u  L e u  
4 0 5  
<210>  SEQ I D  NO 8  
<211>  LENGTH: 1 2 3 0  
<212>  TYPE: DNA 
<213>  ORGANISM: P s e u d o m o n a s  m a l t o p h i l i a  DI -6  
<220>  FEATURE: 
<221>  NAME/KEY: CDS 
<222>  LOCATION: ( 1 ) . . ( 1 2 3 0 )  
<400>  SEQUENCE: 8  
a t g  c a g  a g g  g c a  g a c  g t c  g t a  a t c  g t g  g g a  g c c  g g g  c a t  g g c  g g t  g c a  
M e t  G l n  A r g  A l a  A s p  V a l  V a l  I l e  V a l  G l y  A l a  G l y  H i s  G l y  G l y  A l a  
1 5 1 0  1 5  
c a g  t g c  g c g  a t c  g c c  c t t  c g c  c a g  aac g g c  t t c  g a a  g g c  acc a t c  acc 
G l n  C y s  A l a  I l e  A l a  L e u  A r g  G l n  A s n  G l y  P h e  G l u  G l y  T h r  I l e  T h r  
2 0  2  5  3 0  
g t c  a t c  g g t  c g t  g a g  c c g  g a a  t a t  ccc t a t  g a g  c g t  c c g  c c g  c t c  t c g  
V a l  I l e  G l y  A r g  G l u  P r o  G l u  T y r  P r o  T y r  G l u  A r g  P r o  P r o  L e u  S e r  
aag gaa t a t  t t c  gcg cgc gag aag acc  t t c  gac cgc c t c  t a c  a t c  c g t  
Lys Glu Tyr Phe Ala Arg Glu Lys Thr Phe Asp Arg Leu Tyr I l e  Arg 
5 0  5 5  6  0  
ccg ccg acg t t c  t g g  gcc gag aag aac  a t c  gag t t c  aag c t t  ggc acc  
Pro  Pro  Thr Phe Trp Ala Glu Lys Asn I l e  Glu Phe Lys Leu Gly Thr 
6 5  7  0  7 5  8 0  
gaa g t c  acc  aag g t c  g a t  ccc  aag gcg cac  gaa c t g  acg c t c  t c c  aac  
Glu Val Thr Lys Val Asp Pro  Lys Ala His  Glu Leu Thr Leu S e r  Asn 
8 5  9 0  9  5  
ggc gag agc t a c  g g t  t a t  ggc aag c t c  g t c  t g g  gcc acc  ggc ggc g a t  
Gly Glu S e r  Tyr Gly Tyr Gly Lys Leu Val Trp Ala Thr Gly Gly Asp 
1 0 0  1 0 5  1 1 0  
ccg c g t  cgc c t t  t c t  t g c  cag ggg gcc gac c t c  acc  ggc a t c  cac  gcc 
Pro  Arg Arg Leu S e r  Cys Gln Gly Ala Asp Leu Thr Gly I l e  His  Ala 
1 1 5  1 2 0  1 2 5  
g t g  cgc acc  cgc gag gac t g c  gac acg c t g  a t g  gcc gaa g t c  g a t  gcg 
Val Arg Thr Arg Glu Asp Cys Asp Thr Leu Met Ala Glu Val Asp Ala 
1 3 0  1 3 5  1 4 0  
ggc acg aag aac  a t c  g t c  g t c  a t c  ggc ggc ggc t a c  a t c  g g t  c t g  gaa 
Gly Thr Lys Asn I l e  Val Val I l e  Gly Gly Gly Tyr I l e  Gly Leu Glu 
1 4 5  1 5 0  1 5 5  1 6 0  
gcc g c t  gcg g t g  c t g  t c c  aag a t g  ggc c t c  aag g t c  acc  c t g  c t c  gaa 
Ala Ala Ala Val Leu S e r  Lys Met Gly Leu Lys Val Thr Leu Leu Glu 
1 6 5  1 7 0  1 7 5  
gcg c t t  ccg cgc g t g  c t g  gcg cgc g t t  gcg g g t  gaa gac c t c  t c g  acc  
Ala Leu Pro  Arg Val Leu Ala Arg Val Ala Gly Glu Asp Leu S e r  Thr 
1 8 0  1 8 5  1 9 0  
t t c  t a c  cag aag gaa c a t  g t c  g a t  cac  ggc g t c  gac c t g  cgc acc  gaa 
Phe Tyr Gln Lys Glu His  Val Asp His  Gly Val Asp Leu Arg Thr Glu 
1 9 5  2 0 0  2 0 5  
g t c  a t g  g t c  gac agc c t c  g t c  ggc gaa aac  ggc aag g t c  acc  ggc g t g  
Val Met Val Asp S e r  Leu Val Gly Glu Asn Gly Lys Val Thr Gly Val 
2 1 0  2  1 5  2 2 0  
cag c t t  gcc ggc ggc gaa g t g  a t c  ccg gcc gaa ggc g t c  a t c  g t c  ggc 
Gln Leu Ala Gly Gly Glu Val I l e  Pro  Ala Glu Gly Val I l e  Val Gly 
2 2 5  2 3 0  2 3 5  2 4 0  
a t c  ggc a t c  g t g  c c t  gcc a t c  g g t  ccg c t g  a t c  gcg gcc ggc gcg gcc 
I l e  Gly I l e  Val Pro  Ala I l e  Gly Pro  Leu I l e  Ala Ala Gly Ala Ala 
2 4 5  2 5 0  2 5 5  
ggc gcc aac  ggc g t c  gac g t g  gac gag t a c  t g c  cgc acc  t c g  c t g  ccc  
Gly Ala Asn Gly Val Asp Val Asp Glu Tyr Cys Arg Thr S e r  Leu Pro  
2 6 0  2 6 5  2 7 0  
gac a t c  t a t  gcg a t c  ggc gac t g t  gcg g c t  t t c  gcc t g c  gac t a c  gcc 
Asp I l e  Tyr Ala I l e  Gly Asp Cys Ala Ala Phe Ala Cys Asp Tyr Ala 
2 7 5  2 8 0  2 8 5  
ggc ggc aac  g t g  a t g  cgc g t g  gaa t c g  g t c  cag aac  gcc aac  gac a t g  
Gly Gly Asn Val Met Arg Val Glu S e r  Val Gln Asn Ala Asn Asp Met 
2 9 0  2 9 5  3 0 0  
ggc acc  t g c  g t g  gcc aag gcg a t c  t g c  ggc gac gag aag ccc  t a c  aag 
Gly Thr Cys Val Ala Lys Ala I l e  Cys Gly Asp Glu Lys Pro  Tyr Lys 
3 0 5  3 1 0  3  1 5  3 2 0  
gcg t t c  ccg t g g  t t c  t g g  t c c  aac  cag t a c  gac c t c  aag c t g  cag acc  
Ala Phe Pro  Trp Phe Trp S e r  Asn Gln Tyr Asp Leu Lys Leu Gln Thr 
3 2 5  3 3 0  3 3 5  
gcc ggc a t c  aac  c t g  ggc t t c  gac aag acc  g t g  a t c  cgc ggc a a t  ccg 
Ala Gly I l e  Asn Leu Gly Phe Asp Lys Thr Val I l e  Arg Gly Asn Pro  
3 4 0  3 4 5  3 5 0  
gag gag cgc agc t t c  t c g  g t c  g t c  t a t  c t c  aag gac ggc cgc g t g  g t c  
G l u  G l u  A r g  S e r  P h e  S e r  V a l  V a l  T y r  L e u  L y s  A s p  G l y  A r g  V a l  V a l  
3 5 5  3 6 0  3 6 5  
g c g  c t g  g a c  t g c  g t g  aac a t g  g t c  a a g  g a t  t a c  g t g  c a g  g g c  c g c  a a g  1 1 5 2  
A l a  L e u  A s p  C y s  V a l  A s n  M e t  V a l  L y s  A s p  T y r  V a l  G l n  G l y  A r g  L y s  
3 7 0  3 7 5  3 8 0  
c t g  g t c  g a a  g c c  g g g  g c c  acc ccc g a c  c t c  g a a  g c g  c t g  g c c  g a t  g c c  1 2 0 0  
L e u  V a l  G l u  A l a  G l y  A l a  T h r  P r o  A s p  L e u  G l u  A l a  L e u  A l a  A s p  A l a  
3 8 5  3 9 0  3 9 5  4 0 0  
g g c  a a g  c c g  c t c  a a g  g a a  c t g  caa t a c  t a g  
G l y  L y s  P r o  L e u  L y s  G l u  L e u  G l n  T y r  
4 0 5  
<210>  SEQ I D  NO 9  
<211>  LENGTH: 4 0 9  
<212>  TYPE: PRT 
<213>  ORGANISM: P s e u d o m o n a s  m a l t o p h i l i a  DI -6  
<400>  SEQUENCE: 9  
M e t  G l n  A r g  A l a  A s p  V a l  V a l  I l e  V a l  G l y  A l a  G l y  H i s  G l y  G l y  A l a  
1 5  1 0  1 5  
G l n  C y s  A l a  I l e  A l a  L e u  A r g  G l n  A s n  G l y  P h e  G l u  G l y  T h r  I l e  T h r  
2 0  2  5  3 0  
V a l  I l e  G l y  A r g  G l u  P r o  G l u  T y r  P r o  T y r  G l u  A r g  P r o  P r o  L e u  S e r  
3  5  40  4  5  
L y s  G l u  T y r  P h e  A l a  A r g  G l u  L y s  T h r  P h e  A s p  A r g  L e u  T y r  I l e  A r g  
5 0  5 5  6  0  
P r o  P r o  T h r  P h e  T r p  A l a  G l u  L y s  A s n  I l e  G l u  P h e  L y s  L e u  G l y  T h r  
6 5  7  0  7 5  8 0  
G l u  V a l  T h r  L y s  V a l  A s p  P r o  L y s  A l a  H i s  G l u  L e u  T h r  L e u  S e r  A s n  
8 5  9 0  9  5  
G l y  G l u  S e r  T y r  G l y  T y r  G l y  L y s  L e u  V a l  T r p  A l a  T h r  G l y  G l y  A s p  
1 0 0  1 0 5  1 1 0  
P r o  A r g  A r g  L e u  S e r  C y s  G l n  G l y  A l a  A s p  L e u  T h r  G l y  I l e  H i s  A l a  
1 1 5  1 2 0  1 2 5  
V a l  A r g  T h r  A r g  G l u  A s p  C y s  A s p  T h r  L e u  M e t  A l a  G l u  V a l  A s p  A l a  
1 3 0  1 3 5  1 4 0  
G l y  T h r  L y s  A s n  I l e  V a l  V a l  I l e  G l y  G l y  G l y  T y r  I l e  G l y  L e u  G l u  
1 4 5  1 5 0  1 5 5  1 6 0  
A l a  A l a  A l a  V a l  L e u  S e r  L y s  M e t  G l y  L e u  L y s  V a l  T h r  L e u  L e u  G l u  
1 6 5  1 7 0  1 7 5  
A l a  L e u  P r o  A r g  V a l  L e u  A l a  A r g  V a l  A l a  G l y  G l u  A s p  L e u  S e r  T h r  
1 8 0  1 8 5  1 9 0  
P h e  T y r  G l n  L y s  G l u  H i s  V a l  A s p  H i s  G l y  V a l  A s p  L e u  A r g  T h r  G l u  
1 9 5  2 0 0  2 0 5  
V a l  M e t  V a l  A s p  S e r  L e u  V a l  G l y  G l u  A s n  G l y  L y s  V a l  T h r  G l y  V a l  
2 1 0  2  1 5  2 2 0  
G l n  L e u  A l a  G l y  G l y  G l u  V a l  I l e  P r o  A l a  G l u  G l y  V a l  I l e  V a l  G l y  
2 2 5  2 3 0  2 3 5  2 4 0  
I l e  G l y  I l e  V a l  P r o  A l a  I l e  G l y  P r o  L e u  I l e  A l a  A l a  G l y  A l a  A l a  
2 4 5  2 5 0  2 5 5  
G l y  A l a  A s n  G l y  V a l  A s p  V a l  A s p  G l u  T y r  C y s  A r g  T h r  S e r  L e u  P r o  
2 6 0  2 6 5  2 7 0  
A s p  I l e  T y r  A l a  I l e  G l y  A s p  C y s  A l a  A l a  P h e  A l a  C y s  A s p  T y r  A l a  
2 7 5  2 8 0  2 8 5  
G l y  G l y  A s n  V a l  M e t  A r g  V a l  G l u  S e r  V a l  G l n  A s n  A l a  A s n  A s p  M e t  
2 9 0  2 9 5  3 0 0  
T h r  C y s  V a l  A l a  L y s  A l a  I l e  C y s  G l y  A s p  G l u  L y s  P r o  T y r  L y s  
3 1 0  3  1 5  3 2 0  
A l a  P h e  P r o  T r p  P h e  T r p  S e r  A s n  G l n  T y r  A s p  L e u  L y s  L e u  G l n  T h r  
3 2 5  3 3 0  3 3 5  
A l a  G l y  I l e  A s n  L e u  G l y  P h e  A s p  L y s  T h r  V a l  I l e  A r g  G l y  A s n  P r o  
3 4 0  3 4 5  3 5 0  
G l u  G l u  A r g  S e r  P h e  S e r  V a l  V a l  T y r  L e u  L y s  A s p  G l y  A r g  V a l  V a l  
3 5 5  3 6 0  3 6 5  
A l a  L e u  A s p  C y s  V a l  A s n  M e t  V a l  L y s  A s p  T y r  V a l  G l n  G l y  A r g  L y s  
3 7 0  3 7 5  3 8 0  
L e u  V a l  G l u  A l a  G l y  A l a  T h r  P r o  A s p  L e u  G l u  A l a  L e u  A l a  A s p  A l a  
3 8 5  3 9 0  3 9 5  400  
G l y  L y s  P r o  L e u  L y s  G l u  L e u  G l n  T y r  
4 0 5  
<210>  SEQ I D  NO 1 0  
<211>  LENGTH: 1 0 6  
<212>  TYPE: PRT 
<213>  ORGANISM: R h o d o b a c t e r  c a p s u l a t u s  
<400>  SEQUENCE: 1 0  
A l a  L y s  I l e  I l e  P h e  I l e  G l u  H i s  A s n  G l y  T h r  A r g  H i s  G l u  V a l  G l u  
1 5 1 0  1 5  
A l a  L y s  P r o  G l y  L e u  T h r  V a l  M e t  G l u  A l a  A l a  A r g  A s p  A s n  G l y  V a l  
2 0  2  5  3 0  
P r o  G l y  I l e  A s p  A l a  A s p  C y s  G l y  G l y  A l a  C y s  A l a  C y s  S e r  T h r  C y s  
3  5  40 4  5  
H i s  A l a  T y r  V a l  A s p  P r o  A l a  T r p  V a l  A s p  L y s  L e u  P r o  L y s  A l a  L e u  
5 0  5 5  6  0  
P r o  T h r  G l u  T h r  A s p  M e t  I l e  A s p  P h e  A l a  T y r  G l u  P r o  A s n  P r o  A l a  
6 5  7  0  7 5  8 0  
T h r  S e r  A r g  L e u  T h r  C y s  G l n  I l e  L y s  V a l  T h r  S e r  L e u  L e u  A s p  G l y  
8 5  9 0  9  5  
L e u  V a l  V a l  H i s  L e u  P r o  G l u  L y s  G l n  I l e  
1 0 0  1 0 5  
<210>  SEQ I D  NO 11 
<211>  LENGTH: 1 0 6  
<212>  TYPE: PRT 
<213>  ORGANISM: C a u l o b a c t e r  c r e s c e n t u s  
<400>  SEQUENCE: 1 1  
M e t  A l a  L y s  I l e  T h r  T y r  I l e  G l n  H i s  A s p  G l y  A l a  G l u  G l n  V a l  I l e  
1 5 1 0  1 5  
A s p  V a l  L y s  P r o  G l y  L e u  T h r  V a l  M e t  G l u  G l y  A l a  V a l  L y s  A s n  A s n  
2 0  2  5  3 0  
V a l  P r o  G l y  I l e  A s p  A l a  A s p  C y s  G l y  G l y  A l a  C y s  A l a  C y s  A l a  T h r  
3  5  40 4  5  
C y s  H i s  V a l  T y r  V a l  A s p  G l u  A l a  T r p  L e u  A s p  L y s  T h r  G l y  A s p  L y s  
5 0  5 5  6  0  
S e r  A l a  M e t  G l u  G l u  S e r  M e t  L e u  A s p  P h e  A l a  G l u  A s n  V a l  G l u  P r o  
6 5  7  0  7 5  8 0  
A s n  S e r  A r g  L e u  S e r  C y s  G l n  I l e  L y s  V a l  S e r  A s p  A l a  L e u  A s p  G l y  
8 5  9 0  9  5  
L e u  V a l  V a l  A r g  L e u  P r o  G l u  S e r  G l n  H i s  
1 0 0  1 0 5  
<210>  SEQ I D  NO 1 2  
<211>  LENGTH: 1 0 6  
<212>  TYPE: PRT 
<213>  ORGANISM: R h o d o c o c c u s  e r y t h r o p o l i s  
<400>  SEQUENCE: 1 2  
P r o  T h r  V a l  T h r  T y r  V a l  H i s  P r o  A s p  G l y  T h r  L y s  H i s  G l u  V a l  G l u  
1 5 1 0  1 5  
V a l  P r o  T h r  G l y  L y s  A r g  V a l  M e t  G l n  A l a  A l a  I l e  G l y  A l a  G l y  I l e  
2 0  2  5  3 0  
A s p  G l y  I l e  V a l  A l a  G l u  C y s  G l y  G l y  G l n  A l a  M e t  C y s  A l a  T h r  C y s  
3  5  40 4  5  
H i s  V a l  T y r  V a l  G l u  S e r  P r o  T r p  A l a  A s p  L y s  P h e  P r o  S e r  I l e  S e r  
5 0  5 5  6  0  
G l u  G l u  G l u  A s p  G l u  M e t  L e u  A s p  A s p  T h r  V a l  S e r  P r o  A r g  T h r  G l u  
6 5  7  0  7 5  8 0  
A l a  S e r  A r g  L e u  S e r  C y s  G l n  L e u  V a l  V a l  S e r  A s p  A s p  V a l  A s p  G l y  
8 5  9 0  9  5  
L e u  I l e  V a l  A r g  L e u  P r o  G l u  G l u  G l n  V a l  
1 0 0  1 0 5  
<210>  SEQ I D  NO 1 3  
<211>  LENGTH: 1 0 6  
<212>  TYPE: PRT 
<213>  ORGANISM: P s e u d o m o n a s  p u t i d a  
<400>  SEQUENCE: 1 3  
S e r  L y s  V a l  V a l  T y r  V a l  S e r  H i s  A s p  G l y  T h r  A r g  A r g  G l u  L e u  A s p  
1 5 1 0  1 5  
V a l  A l a  A s p  G l y  V a l  S e r  L e u  M e t  G l n  A l a  A l a  V a l  S e r  A s n  G l y  I l e  
2 0  2  5  3 0  
T y r  A s p  I l e  V a l  G l y  A s p  C y s  G l y  G l y  S e r  A l a  S e r  C y s  A l a  T h r  C y s  
3  5  40 4  5  
H i s  V a l  T y r  V a l  A s n  G l u  A l a  P h e  T h r  A s p  L y s  V a l  P r o  A l a  A l a  A s n  
5 0  5 5  6  0  
G l u  A r g  G l u  I l e  G l y  M e t  L e u  G l u  C y s  V a l  T h r  A l a  G l u  L e u  L y s  P r o  
6 5  7  0  7 5  8 0  
A s n  S e r  A r g  L e u  C y s  C y s  G l n  I l e  I l e  M e t  T h r  P r o  G l u  L e u  A s p  G l y  
8 5  9 0  9  5  
I l e  V a l  V a l  A s p  V a l  P r o  A s p  A r g  G l n  T r p  
1 0 0  1 0 5  
<210>  SEQ I D  NO 1 4  
<211>  LENGTH: 1 0 5  
<212>  TYPE: PRT 
<213>  ORGANISM: P s e u d o m o n a s  s p .  
<400>  SEQUENCE: 1 4  
P r o  A r g  V a l  V a l  P h e  I l e  A s p  G l u  G l n  S e r  G l y  G l u  T y r  A l a  V a l  A s p  
1 5 1 0  1 5  
A l a  G l n  A s p  G l y  G l n  S e r  L e u  M e t  G l u  V a l  A l a  T h r  G l n  A s n  G l y  V a l  
2 0  2  5  3 0  
P r o  G l y  I l e  V a l  A l a  G l u  C y s  G l y  G l y  S e r  C y s  V a l  C y s  A l a  T h r  C y s  
3  5  40 4  5  
A r g  I l e  G l u  I l e  G l u  A s p  A l a  T r p  V a l  G l u  I l e  V a l  G l y  G l u  A l a  A s n  
5 0  5 5  6  0  
P r o  A s p  G l u  A s n  A s p  L e u  L e u  G l n  S e r  T h r  G l y  G l u  P r o  M e t  T h r  A l a  
6 5  7  0  7 5  8 0  
G l y  T h r  A r g  L e u  S e r  C y s  G l n  V a l  P h e  I l e  A s p  P r o  S e r  M e t  A s p  G l y  
8 5  9 0  9  5  
L e u  I l e  V a l  A r g  V a l  P r o  L e u  P r o  A l a  
1 0 0  1 0 5  
<210>  SEQ I D  NO 1 5  
<211>  LENGTH: 409  
<212>  TYPE: PRT 
<213>  ORGANISM: S p h i n g o m o n a s  s p .  
<400>  SEQUENCE: 1 5  
M e t  A r g  S e r  A l a  A s p  V a l  V a l  I l e  V a l  G l y  A l a  G l y  H i s  A l a  G l y  A l a  
1 5 1 0  1 5  
G l n  C y s  A l a  I l e  A l a  L e u  A r g  G l n  A l a  G l y  T y r  G l u  G l y  S e r  I l e  A l a  
2 0  2  5  3 0  
L e u  V a l  G l y  A r g  G l u  A s n  G l u  V a l  P r o  T y r  G l u  A r g  P r o  P r o  L e u  S e r  
3  5  40 4  5  
L y s  G l u  T y r  P h e  S e r  A r g  G l u  L y s  S e r  P h e  G l u  A r g  L e u  T y r  I l e  A r g  
5 0  5 5  6  0  
P r o  P r o  G l u  P h e  T r p  A r g  G l u  L y s  A s p  I l e  H i s  L e u  T h r  L e u  G l y  I l e  
6 5  7  0  7 5  8 0  
G l u  V a l  S e r  A l a  V a l  A s p  P r o  G l y  S e r  L y s  V a l  L e u  T h r  L e u  S e r  A s p  
8 5  9 0  9  5  
G l y  S e r  A l a  P h e  A l a  T y r  G l y  G l n  L e u  V a l  T r p  A l a  T h r  G l y  G l y  A s p  
1 0 0  1 0 5  1 1 0  
P r o  A r g  L y s  L e u  A l a  C y s  P r o  G l y  A l a  G l u  L e u  S e r  G l y  V a l  H i s  A l a  
1 1 5  1 2 0  1 2 5  
I l e  A r g  T h r  A r g  A l a  A s p  C y s  A s p  A r g  L e u  M e t  A l a  G l u  I l e  A s p  A r g  
1 3 0  1 3 5  1 4 0  
G l y  L e u  T h r  G l n  V a l  V a l  V a l  V a l  G l y  G l y  G l y  T y r  I l e  G l y  L e u  G l u  
1 4 5  1 5 0  1 5 5  1 6 0  
A l a  A l a  A l a  V a l  L e u  T h r  L y s  L e u  A s n  C y s  H i s  V a l  T h r  L e u  L e u  G l u  
1 6 5  1 7 0  1 7 5  
A l a  M e t  P r o  A r g  V a l  L e u  A l a  A r g  V a l  A l a  G l y  T h r  G l u  L e u  S e r  T h r  
1 8 0  1 8 5  1 9 0  
P h e  T y r  G l u  A s n  G l u  H i s  A r g  G l y  H i s  G l y  V a l  A s p  L e u  A r g  T h r  G l y  
1 9 5  2 0 0  2 0 5  
I l e  T h r  V a l  A l a  A l a  L e u  G l u  G l y  G l n  G l u  S e r  V a l  T h r  G l y  V a l  A r g  
2 1 0  2  1 5  2 2 0  
L e u  G l y  A s p  G l y  S e r  V a l  L e u  P r o  A l a  G l n  A l a  V a l  I l e  V a l  G l y  I l e  
2 2 5  2 3 0  2 3 5  2 4 0  
G l y  I l e  V a l  P r o  A l a  V a l  A l a  P r o  L e u  I l e  G l u  A l a  G l y  A l a  A l a  G l y  
2 4 5  2 5 0  2 5 5  
A s p  G l y  G l y  V a l  T h r  V a l  A s p  G l u  T y r  C y s  A r g  T h r  S e r  L e u  P r o  A s p  
2 6 0  2 6 5  2 7 0  
V a l  P h e  A l a  I l e  G l y  A s p  C y s  A l a  S e r  P h e  S e r  C y s  S e r  P h e  A l a  A s p  
2 7 5  2 8 0  2 8 5  
G l y  A r g  V a l  L e u  A r g  V a l  G l u  S e r  V a l  G l n  A s n  A l a  A s n  A s p  G l n  A l a  
2 9 0  2 9 5  3 0 0  
S e r  C y s  V a l  A l a  L y s  T h r  I l e  C y s  G l y  A s p  P r o  G l n  P r o  T y r  A r g  A l a  
3 0 5  3 1 0  3  1 5  3 2 0  
P h e  P r o  T r p  P h e  T r p  S e r  A s n  G l n  T y r  A s p  L e u  A r g  L e u  G l n  T h r  A l a  
3 2 5  3 3 0  3 3 5  
G l y  L e u  S e r  L e u  G l y  T y r  A s p  G l n  T h r  V a l  V a l  A r g  G l y  A s p  P r o  A l a  
3 4 0  3 4 5  3 5 0  
V a l  A r g  S e r  P h e  S e r  V a l  L e u  T y r  L e u  L y s  G l n  G l y  A r g  V a l  I l e  A l a  
3 5 5  3 6 0  3 6 5  
L e u  A s p  C y s  V a l  A s n  M e t  V a l  L y s  A s p  T y r  V a l  G l n  G l y  A r g  L y s  L e u  
3 7 0  3 7 5  3 8 0  
V a l  G l u  A l a  A s n  V a l  C y s  V a l  S e r  P r o  G l u  G l n  L e u  V a l  A s p  T h r  G l y  
3 8 5  3 9 0  3 9 5  400  
L e u  A l a  L e u  L y s  A s p  L e u  I l e  P r o  V a l  
4 0 5  
<210>  SEQ I D  NO 1 6  
<211>  LENGTH: 427  
<212>  TYPE: PRT 
<213>  ORGANISM: R h o d o c o c c u s  e r y t h r o p o l i s  
<400>  SEQUENCE: 1 6  
S e r  I l e  V a l  I l e  I l e  G l y  S e r  G l y  G l n  A l a  G l y  P h e  G l u  A l a  A l a  V a l  
1 5  1 0  1 5  
S e r  L e u  A r g  S e r  H i s  G l y  P h e  S e r  G l y  T h r  I l e  T h r  L e u  V a l  G l y  A s p  
2 0  2  5  3 0  
G l u  P r o  G l y  V a l  P r o  T y r  G l n  A r g  P r o  P r o  L e u  S e r  L y s  A l a  T y r  L e u  
3  5  40 4  5  
H i s  S e r  A s p  P r o  A s p  A r g  G l u  S e r  L e u  A l a  L e u  A r g  P r o  A l a  G l n  T y r  
5 0  5 5  6  0  
P h e  A s p  A s p  H i s  A r g  I l e  T h r  L e u  T h r  C y s  G l y  L y s  P r o  V a l  V a l  A r g  
6 5  7  0  7 5  8 0  
I l e  A s p  A r g  A s p  A l a  G l n  A r g  V a l  G l u  L e u  I l e  A s p  A l a  T h r  A l a  I l e  
8 5  9 0  9  5  
G l u  T y r  A s p  H i s  L e u  I l e  L e u  A l a  T h r  G l y  A l a  A r g  A s n  A r g  L e u  L e u  
1 0 0  1 0 5  1 1 0  
P r o  V a l  P r o  G l y  A l a  A s n  L e u  P r o  G l y  V a l  H i s  T y r  L e u  A r g  T h r  A l a  
1 1 5  1 2 0  1 2 5  
G l y  G l u  A l a  G l u  S e r  L e u  T h r  S e r  S e r  M e t  A l a  S e r  C y s  S e r  S e r  L e u  
1 3 0  1 3 5  1 4 0  
V a l  V a l  I l e  G l y  A l a  G l y  P h e  I l e  G l y  L e u  G l u  V a l  A l a  A l a  A l a  A l a  
1 4 5  1 5 0  1 5 5  1 6 0  
A r g  L y s  L y s  G l y  L e u  A s p  V a l  T h r  V a l  V a l  G l u  A l a  M e t  A s p  A r g  P r o  
1 6 5  1 7 0  1 7 5  
M e t  A l a  A r g  A l a  L e u  S e r  S e r  V a l  M e t  S e r  G l y  T y r  P h e  S e r  T h r  A l a  
1 8 0  1 8 5  1 9 0  
H i s  T h r  G l u  H i s  G l y  V a l  H i s  M e t  A r g  L e u  S e r  T h r  G l y  V a l  L y s  T h r  
1 9 5  2 0 0  2 0 5  
I l e  A s n  A l a  A l a  A s p  G l y  A r g  A l a  A l a  G l y  V a l  T h r  T h r  A s n  S e r  G l y  
2 1 0  2  1 5  2 2 0  
A s p  V a l  I l e  H i s  A l a  A s p  A l a  V a l  V a l  V a l  G l y  I l e  G l y  V a l  V a l  P r o  
2 2 5  2 3 0  2 3 5  2 4 0  
A s n  I l e  G l u  L e u  A l a  A l a  L e u  T h r  G l y  L e u  P r o  V a l  A s p  A s n  G l y  I l e  
2 4 5  2 5 0  2 5 5  
V a l  V a l  A s p  G l u  T y r  L e u  A r g  T h r  P r o  A s p  G l u  A s n  I l e  S e r  A l a  I l e  
2 6 0  2 6 5  2 7 0  
G l y  A s p  C y s  A l a  A l a  T y r  P r o  I l e  P r o  G l y  L y s  A l a  G l y  L e u  V a l  A r g  
2 7 5  2 8 0  2 8 5  
L e u  G l u  S e r  V a l  G l n  A s n  A l a  V a l  A s p  G l n  A l a  A r g  C y s  L e u  A l a  A l a  
G l n  L e u  T h r  G l y  T h r  S e r  T h r  H i s  T y r  A r g  S e r  V a l  P r o  T r p  P h e  T r p  
3 0 5  3 1 0  3  1 5  3 2 0  
S e r  G l u  G l n  T y r  G l u  S e r  L y s  L e u  G l n  M e t  A l a  G l y  L e u  T h r  A l a  G l y  
3 2 5  3 3 0  3 3 5  
A l a  A s p  T h r  H i s  V a l  V a l  A r g  G l y  S e r  V a l  A s p  S e r  G l y  V a l  P h e  S e r  
3 4 0  3 4 5  3 5 0  
I l e  P h e  C y s  P h e  L e u  G l y  T h r  A r g  L e u  L e u  G l y  V a l  G l u  S e r  V a l  A s n  
3 5 5  3 6 0  3 6 5  
L y s  P r o  A r g  A s p  H i s  M e t  A l a  A l a  A r g  L y s  I l e  L e u  A l a  T h r  G l u  M e t  
3 7 0  3 7 5  3 8 0  
P r o  L e u  T h r  P r o  G l u  G l n  A l a  A l a  A s p  T h r  A s p  P h e  A s p  L e u  L y s  L e u  
3 8 5  3 9 0  3 9 5  400  
A l a  I l e  A l a  A r g  H i s  L y s  A s p  T h r  H i s  G l u  L y s  A s p  G l u  V a l  A l a  S e r  
4 0 5  410  4 1 5  
A l a  A s p  I l e  G l y  G l u  A r g  G l n  V a l  V a l  A l a  S e r  
420  4 2 5  
<210>  SEQ I D  NO 1 7  
<211>  LENGTH: 422  
<212>  TYPE: PRT 
<213>  ORGANISM: P s e u d o m o n a s  p u t i d a  
<400>  SEQUENCE: 1 7  
M e t  A s n  A l a  A s n  A s p  A s n  V a l  V a l  I l e  V a l  G l y  T h r  G l y  L e u  A l a  G l y  
1 5  1 0  1 5  
V a l  G l u  V a l  A l a  P h e  G l y  L e u  A r g  A l a  S e r  G l y  T r p  G l u  G l y  A s n  I l e  
2 0  2  5  3 0  
A r g  L e u  V a l  G l y  A s p  A l a  T h r  V a l  I l e  P r o  H i s  H i s  L e u  P r o  P r o  L e u  
3  5  40 4  5  
S e r  L y s  A l a  T y r  L e u  A l a  G l y  L y s  A l a  T h r  A l a  G l u  S e r  L e u  T y r  L e u  
5 0  5 5  6  0  
A r g  T h r  P r o  A s p  A l a  T y r  A l a  A l a  G l n  A s n  I l e  G l n  L e u  L e u  G l y  G l y  
6 5  7  0  7 5  8 0  
T h r  G l n  V a l  T h r  A l a  I l e  A s n  A r g  A s p  A r g  G l n  G l n  V a l  I l e  L e u  S e r  
8 5  9 0  9  5  
A s p  G l y  A r g  A l a  L e u  A s p  T y r  A s p  A r g  L e u  V a l  L e u  A l a  T h r  G l y  G l y  
1 0 0  1 0 5  1 1 0  
A r g  P r o  A r g  P r o  L e u  P r o  V a l  A l a  S e r  G l y  A l a  V a l  G l y  L y s  A l a  A s n  
1 1 5  1 2 0  1 2 5  
A s n  P h e  A r g  T y r  L e u  A r g  T h r  L e u  G l u  A s p  A l a  G l u  C y s  I l e  A r g  A r g  
1 3 0  1 3 5  1 4 0  
G l n  L e u  I l e  A l a  A s p  A s n  A r g  L e u  V a l  V a l  I l e  G l y  G l y  G l y  T y r  I l e  
1 4 5  1 5 0  1 5 5  1 6 0  
G l y  L e u  G l u  V a l  A l a  A l a  T h r  A l a  I l e  L y s  A l a  A s n  M e t  H i s  V a l  T h r  
1 6 5  1 7 0  1 7 5  
L e u  L e u  A s p  T h r  A l a  A l a  A r g  V a l  L e u  G l u  A r g  V a l  T h r  A l a  P r o  P r o  
1 8 0  1 8 5  1 9 0  
V a l  S e r  A l a  P h e  T y r  G l u  H i s  L e u  H i s  A r g  G l u  A l a  G l y  V a l  A s p  I l e  
1 9 5  2 0 0  2 0 5  
A r g  T h r  G l y  T h r  G l n  V a l  C y s  G l y  P h e  G l u  M e t  S e r  T h r  A s p  G l n  G l n  
2 1 0  2  1 5  2 2 0  
L y s  V a l  T h r  A l a  V a l  L e u  C y s  G l u  A s p  G l y  T h r  A r g  L e u  P r o  A l a  A s p  
2 2 5  2 3 0  2 3 5  2 4 0  
L e u  V a l  I l e  A l a  G l y  I l e  G l y  L e u  I l e  P r o  A s n  C y s  G l u  L e u  A l a  S e r  
2 4 5  2 5 0  2 5 5  
A l a  A l a  G l y  L e u  G l n  V a l  A s p  A s n  G l y  I l e  V a l  I l e  A s n  G l u  H i s  M e t  
2 6 0  2 6 5  2 7 0  
G l n  T h r  S e r  A s p  P r o  L e u  I l e  M e t  A l a  V a l  G l y  A s p  C y s  A l a  A r g  P h e  
2 7 5  2 8 0  2 8 5  
H i s  S e r  G l n  L e u  T y r  A s p  A r g  T r p  V a l  A r g  I l e  G l u  S e r  V a l  P r o  A s n  
2 9 0  2 9 5  3 0 0  
A l a  L e u  G l u  G l n  A l a  A r g  L y s  I l e  A l a  A l a  I l e  L e u  C y s  G l y  L y s  V a l  
3 0 5  3 1 0  3  1 5  3 2 0  
P r o  A r g  A s p  G l u  A l a  A l a  P r o  T r p  P h e  T r p  S e r  A s p  G l n  T y r  G l u  I l e  
3 2 5  3 3 0  3 3 5  
G l y  L e u  L y s  M e t  V a l  G l y  L e u  S e r  G l u  G l y  T y r  A s p  A r g  I l e  I l e  V a l  
3 4 0  3 4 5  3 5 0  
A r g  G l y  S e r  L e u  A l a  G l n  P r o  A s p  P h e  S e r  V a l  P h e  T y r  L e u  G l n  G l y  
3 5 5  3 6 0  3 6 5  
A s p  A r g  V a l  L e u  A l a  V a l  A s p  T h r  V a l  A s n  A r g  P r o  V a l  G l u  P h e  A s n  
3 7 0  3 7 5  3 8 0  
G l n  S e r  L y s  G l n  I l e  I l e  T h r  A s p  A r g  L e u  P r o  V a l  G l u  P r o  A s n  L e u  
3 8 5  3 9 0  3 9 5  400  
L e u  G l y  A s p  G l u  S e r  V a l  P r o  L e u  L y s  G l u  I l e  I l e  A l a  A l a  A l a  L y s  
4 0 5  410  4 1 5  
A l a  G l u  L e u  S e r  S e r  A l a  
420  
<210>  SEQ I D  NO 1 8  
<211>  LENGTH: 409  
<212>  TYPE: PRT 
<213>  ORGANISM: P s e u d o m o n a s  s p .  
<400>  SEQUENCE: 1 8  
M e t  G l y  G l u  A r g  A r g  A s p  T h r  T h r  V a l  I l e  V a l  G l y  A l a  G l y  H i s  A l a  
1 5  1 0  1 5  
G l y  T h r  A l a  A l a  A l a  P h e  P h e  L e u  A r g  G l u  P h e  G l y  T y r  H i s  G l y  A r g  
2 0  2  5  3 0  
V a l  L e u  L e u  L e u  S e r  A l a  G l u  T h r  G l n  H i s  P r o  T y r  G l n  A r g  P r o  P r o  
3  5  40 4  5  
L e u  S e r  L y s  G l u  T y r  L e u  L e u  A l a  G l n  H i s  S e r  T h r  P r o  S e r  L e u  L e u  
5 0  5 5  6  0  
L y s  G l y  L y s  A s p  S e r  T y r  A l a  A r g  A l a  A s p  I l e  G l u  L e u  C y s  L e u  G l n  
6 5  7  0  7 5  8 0  
A s p  A s p  V a l  L e u  S e r  I l e  T h r  P r o  A l a  S e r  A r g  G l n  V a l  L y s  S e r  S e r  
8 5  9 0  9  5  
G l n  G l y  S e r  T y r  T h r  T y r  A s p  H i s  L e u  I l e  L e u  A l a  T h r  G l y  S e r  H i s  
1 0 0  1 0 5  1 1 0  
P r o  A r g  P h e  M e t  A l a  T h r  L e u  G l y  G l n  A l a  A s p  A s n  L e u  C y s  T y r  L e u  
1 1 5  1 2 0  1 2 5  
S e r  A s p  T r p  A s p  A s p  A l a  G l y  A r g  I l e  A r g  G l n  G l n  L e u  G l y  G l u  A l a  
1 3 0  1 3 5  1 4 0  
S e r  A r g  I l e  V a l  V a l  L e u  G l y  G l y  G l y  P h e  I l e  G l y  L e u  G l u  I l e  A l a  
1 4 5  1 5 0  1 5 5  1 6 0  
S e r  S e r  A l a  C y s  L y s  M e t  G l y  L y s  H i s  V a l  T h r  V a l  I l e  G l u  A r g  A l a  
1 6 5  1 7 0  1 7 5  
P r o  A r g  L e u  L e u  S e r  A r g  V a l  V a l  S e r  G l u  A l a  P h e  A l a  T h r  P h e  I l e  
1 8 0  1 8 5  1 9 0  
G l y  A s p  I l e  H i s  L e u  G l y  A s n  G l y  I l e  G l u  L e u  A r g  L e u  G l y  G l u  G l u  
1 9 5  2 0 0  2 0 5  
V a l  A r g  G l u  V a l  A r g  A r g  C y s  T h r  S e r  G l y  V a l  A r g  V a l  A s p  A l a  V a l  
2 1 0  2  1 5  2 2 0  
P h e  L e u  S e r  A s p  G l y  G l n  L e u  L e u  G l u  C y s  A s p  M e t  L e u  V a l  I l e  G l y  
2 2 5  2 3 0  2 3 5  2 4 0  
V a l  G l y  S e r  G l u  P r o  A r g  M e t  G l u  L e u  A l a  T h r  A l a  A l a  G l y  L e u  A l a  
2 4 5  2 5 0  2 5 5  
C y s  A l a  S e r  G l y  V a l  L e u  V a l  A s p  G l u  H i s  C y s  H i s  T h r  S e r  A s p  P r o  
2 6 0  2 6 5  2 7 0  
P h e  I l e  S e r  A l a  I l e  G l y  A s p  C y s  V a l  A l a  V a l  C y s  P r o  S e r  P r o  G l y  
2 7 5  2 8 0  2 8 5  
H i s  G l n  L e u  P r o  A r g  A r g  G l u  S e r  V a l  G l n  A s n  A l a  T h r  G l u  G l n  A l a  
2 9 0  2 9 5  3 0 0  
A r g  L e u  V a l  A l a  A l a  A r g  L e u  S e r  G l y  A r g  P r o  V a l  P r o  P r o  V a l  G l n  
3 0 5  3 1 0  3  1 5  3 2 0  
T h r  P r o  T r p  P h e  T r p  S e r  A s p  G l n  L e u  G l n  A l a  A r g  I l e  A s n  L e u  A l a  
3 2 5  3 3 0  3 3 5  
G l y  G l u  A r g  P r o  A l a  G l n  G l y  G l n  V a l  I l e  V a l  A r g  A r g  T y r  G l y  G l y  
3 4 0  3 4 5  3 5 0  
A s p  L y s  V a l  S e r  M e t  L e u  T y r  L e u  G l n  A s p  G l n  G l n  L e u  V a l  A l a  I l e  
3 5 5  3 6 0  3 6 5  
G l u  A l a  C y s  A s n  M e t  P r o  G l y  A s p  C y s  L e u  L e u  A l a  A r g  A r g  A l a  I l e  
3 7 0  3 7 5  3 8 0  
G l y  G l n  A s n  H i s  S e r  L e u  A s p  L e u  A l a  A r g  L e u  V a l  A s p  A l a  A s p  V a l  
3 8 5  3 9 0  3 9 5  400  
P r o  L e u  L y s  A s p  A l a  L e u  H i s  P h e  A l a  
4 0 5  
We claim: 40 5. The DNA construct of claim 1, wherein said ferredoxin 
1. A DNA construct comprising: comprises an amino acid sequence of SEQ ID NO:5. 
a) a DNA sequence encoding a dicamba-degrading oxy- 6. The DNA construct of claim 1, wherein the ferredoxin 
genase comprising an amino acid sequence of SEQ ID binds a single 2Fe-2s iron-sulfur cluster. 
NO:3, wherein the dicamba-degrading oxygenase cata- 7. The DNA construct of claim 1, wherein said ferredoxin 
lyzes the oxidation of dicamba to 3,6-dichlorsalicylic 45 is encoded by a nucleotide sequence which has codons 
acid (DCSA); selected for optimized expression in dicotyledonous plants. 
b) a DNA sequence encoding a ferredoxin, wherein said 8. The DNA construct of claim 1, wherein said reductase 
ferredoxin comprises an amino acid sequence that is at comprises the amino acid sequence of SEQ ID NO:7. 
least about 65% identical to the amino acid sequence of 9. The DNA construct of claim 1, wherein said reductase 
SEQ ID NO:5, wherein the ferredoxin is an electron 50 is encoded by the nucleotide sequence of SEQ ID NO:6. 
shuttle; and 10. The DNAconstruct of claim 1, wherein said reductase 
c) a DNA sequence encoding a reductase, wherein said comprises the amino avid sequence of SEQ ID NO:9. 
reductase comprises an amino acid sequence that is at 11. The DNA construct of claim 1, wherein said reductase 
least about 85% identical to an amino acid sequence is encoded by the nucleotide sequence of SEQ ID NO:& 
selected from the group consisting of SEQ ID NO:7 55 12. The DNA construct of claim 1, wherein the reductase 
and SEQ ID NO:9, wherein said reductase catalyzes the has a binding site for a FAD flavin moiety. 
reduction of a protein in the presence of NADH; 13. The DNA construct of claim 1 which comprises a 
wherein each of said DNA sequences of (a)-(c) is opera- vector. 
tively linked to an expression control sequence. 14. A transgenic host cell that has been transformed with: 
2. The DNA construct of claim 1, wherein said dicamba- 60 a) a first DNA sequence encoding a dicamba-degrading 
degrading oxygenase is encoded by the nucleotide sequence oxygenase comprising an amino acid sequence of SEQ 
of SEQ ID NO:2. ID NO:3, wherein the dicamba-degrading oxygenase 
3. The DNA construct of claim 1, wherein said ferredoxin catalyzes the oxidation of dicamba to 3,6-dichlorsali- 
comprises an amino acid sequence that is at least about 85% cylic acid (DCSA); 
identical to the amino acid sequence of SEQ ID NO:5. 65 b) a second DNA sequence encoding a ferredoxin, 
4. The DNA construct of claim 1, wherein said ferredoxin wherein said ferredoxin comprises an amino acid 
is encoded by the nucleotide sequence of SEQ ID NO:4. sequence that is at least about 65% identical to the 
US 7,105,724 B2 
63 64 
amino acid sequence of SEQ ID NO:5, wherein the b) a second DNA sequence encoding a ferredoxin, 
ferredoxin is an electron shuttle; and wherein said ferredoxin comprises an amino acid 
c) a third DNA sequence encoding a reductase, wherein sequence that is at least about 65% identical to the 
said reductase comprises an amino acid sequence that amino acid sequence of SEQ ID NO:5, wherein the 
is at least about 85% identical to an amino acid 5 ferredoxin is an electron shuttle, and 
sequence selected from the group consisting of SEQ ID c) a third DNA sequence encoding a reductase, wherein 
NO:7 and SEQ ID NO:9, wherein said reductase cata- said reductase comprises an amino acid sequence that 
lyzes the reduction of a protein in the presence of is at least about 85% identical to an amino acid 
NADH; sequence selected from the group consisting of SEQ ID 
wherein each of said DNA sequences is operatively linked 10 NO:7 and SEQ ID NO:9, wherein said reductase cata- 
to an expression control sequence. lyzes the reduction of a protein in the presence of 
15. The transgenic host cell of claim 14, when said NADH; 
dicamba degrading oxygenase is encoded by the nucleotide wherein each of said DNA sequences is operatively linked 
sequence of SEQ ID NO:2. to an expression control sequence. 
16. The transgenic host cell of claim 14, wherein said 15 27, The transgenic plant or plant part of claim 26, wherein 
ferredoxin comprises an amino acid sequence that is at least said dicmba degrading oxygenase is encoded by the nucle- 
about 85% identical to the amino acid sequence of SEQ ID otide sequence of SEQ ID NO:2. 
NO:5. 28. The transgenic plant or plant part of claim 26, wherein 
17. The transgenic host cell of claim 14 wherein said said ferredoxin comprises an amino acid sequence that is at 
ferredoxin is encoded by the nucleotide sequence of SEQ ID 20 least about 85% identical to the amino acid sequence of SEQ 
NO:4. ID NO:5. 
18.   he transgenic host cell of claim 14, wherein said 29. The transgenic plant or plant part of claim 26, wherein 
ferredoxin is encoded by a nucleotide sequence which has said ferredoxin is encoded by the nucleotide sequence of 
codons selected for optimized expression in dicotyledonous SEQ ID ~ 0 ~ 4 ,  
plants. 25 30. The transgenic plant or plant part of claim 26, wherein 
19. The transgenic host cell of claim 14, wherein said said ferredoxin is encoded by a nucleotide sequence which 
ferredoxin comprises an amino acid sequence of SEQ ID has codons selected for optimized expression in dicotyle- 
NO:5. donous plants. 
20. The transgenic host cell of claim 14, wherein said 31, The transgenic plant or plant part of claim 26, wherein 
reductase comprises the amino acid sequence of SEQ ID 30 said ferredoxin comprises an amino acid sequence of SEQ 
NO:7. ID NO:5. 
21. The transgenic host 14, wherein said 32, The transgenic plant or plant part of claim 26, wherein 
reductase is encoded by the nucleotide sequence of SEQ ID said reductase comprises the amino acid sequence of SEQ NO:6. ID NO:7. 22. The transgenic host cell of claim 14, wherein said 35 33. The transgenic plant or plant part of claim 26, wherein 
reductase comprises the amino acid sequence of SEQ ID 
NO:9. said reductase is encoded by the nucleotide sequence of SEQ 
23. The transgenic host cell of claim 14, wherein said ID NO:6. 
reductase is encoded by the nucleotide sequence of SEQ ID 34. The transgenic plant or plant part of 26, wherein 
NO:& 40 said reductase comprises the amino acid sequence of SEQ 
24. The transgenic host cell of claim 14, which is a plant ID NO:9. 
cell. 35. The transgenic plant or plant part of claim 26, wherein 
25, ~h~ transgenic host cell of claim 14, which is a said reductase is encoded by the nucleotide sequence of SEQ 
microorganism. ID NO:8. 
26. A transgenic plant or part of a plant that has been 45 36. The transgenic plant or plant Part of claim 26, wherein 
transformed with: the plant is a broadleaf plant which is tolerant to dicamba. 
a) a first DNA sequence encoding a dicamba-degrading 37. A method of controlling weeds in a field containing a 
oxygenase, wherein said dicamba-degrading oxyge- dicamba-tolerant transgenic plant according to claim 26, the 
nase comprises an amino acid sequence of SEQ ID method comprising applying an amount of dicamba to the 
NO:3, wherein the dicamba-degrading oxygenase cata- 50 field effective to control the weeds in the field. 
lyzes the oxidation of dicamba to 3,6-dichlorsalicylic 
acid (DCSA); * * * * *  
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